<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>b54818ttexv2w1.htm
<DESCRIPTION>EX-2.1 AGREEMENT & PLAN OF MERGER DATED AS OF APRIL 21, 2005
<TEXT>
<HTML>
<HEAD>
<TITLE>Ex-2.1 Agreement & Plan Merger dated as of 4-21-05</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<B>Exhibit&nbsp;2.1</B>
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 3pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<B>EXECUTION COPY</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 21pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>dated as of</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>April&nbsp;21, 2005</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>among</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>TRANSKARYOTIC THERAPIES, INC.,</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>SHIRE PHARMACEUTICALS GROUP PLC</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>and</B>
</DIV>

<DIV align="center" style="font-size: 10pt;">
<B>SPARTA ACQUISITION CORPORATION</B>
</DIV>

<DIV style="margin-top: 3pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">

</DIV>

<DIV align="left" style="font-size: 10pt;">
<!-- TOC -->
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name="tocpage"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<B>TABLE OF CONTENTS</B>
</DIV>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; margin-top: 12pt; ">

<TR style="font-size: 1pt;">
    <TD width="19%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<TR style="font-size: 8pt;">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center" nowrap><B>Page</B></TD><TD></TD>
</TR>

<TR valign="bottom" style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD><TD></TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;1<BR>
     </FONT>Definitions</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#101'>SECTION&nbsp;1.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#101'>Definitions</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>1</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#102'>SECTION&nbsp;1.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#102'>Other Definitional And Interpretative
    Provisions</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>7</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;2<BR>
     </FONT>The Merger</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#103'>SECTION&nbsp;2.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#103'>The Merger</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>8</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#104'>SECTION&nbsp;2.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#104'>Conversion of Shares</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>9</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#105'>SECTION&nbsp;2.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#105'>Surrender and Payment</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>9</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#106'>SECTION&nbsp;2.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#106'>Dissenting Shares</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>10</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#107'>SECTION&nbsp;2.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#107'>Company Stock Options</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>11</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#108'>SECTION&nbsp;2.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#108'>Adjustments</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>12</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#109'>SECTION&nbsp;2.07.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#109'>Withholding Rights</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>12</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#110'>SECTION&nbsp;2.08.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#110'>Lost Certificates</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>12</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;3<BR>
     </FONT>The Surviving Corporation</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#111'>SECTION&nbsp;3.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#111'>Certificate of Incorporation</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>13</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#112'>SECTION&nbsp;3.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#112'>Bylaws</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>13</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#113'>SECTION&nbsp;3.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#113'>Directors and Officers</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>13</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;4<BR>
     </FONT>Representations and Warranties of the Company</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#114'>SECTION&nbsp;4.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#114'>Corporate Existence and Power</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>13</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#115'>SECTION&nbsp;4.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#115'>Corporate Authorization</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>14</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#116'>SECTION&nbsp;4.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#116'>Governmental Authorization</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>14</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#117'>SECTION&nbsp;4.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#117'><I>Non-contravention</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>15</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#118'>SECTION&nbsp;4.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#118'>Capitalization</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>15</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#119'>SECTION&nbsp;4.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#119'>Subsidiaries</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>16</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#120'>SECTION&nbsp;4.07.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#120'>SEC Filings; Sarbanes-Oxley Act</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>17</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#121'>SECTION&nbsp;4.08.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#121'>Financial Statements</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>18</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#122'>SECTION&nbsp;4.09.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#122'>Financial Controls</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>18</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#123'>SECTION&nbsp;4.10.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#123'>Disclosure Documents</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>18</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#124'>SECTION&nbsp;4.11.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#124'>Absence of Certain Changes</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>19</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#125'>SECTION&nbsp;4.12.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#125'>No Undisclosed Material
    Liabilities</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>20</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>
</CENTER>

<P align="center" style="font-size: 10pt;">i

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; ">

<TR style="font-size: 1pt;">
    <TD width="19%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<TR style="font-size: 8pt;">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center" nowrap><B>Page</B></TD><TD></TD>
</TR>

<TR valign="bottom" style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD><TD></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#126'>SECTION&nbsp;4.13.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#126'>Compliance with Laws and Court
    Orders</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>21</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#127'>SECTION&nbsp;4.14.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#127'>Litigation</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>21</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#128'>SECTION&nbsp;4.15.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#128'>Finders&#146; Fees</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>21</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#129'>SECTION&nbsp;4.16.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#129'>Taxes</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>21</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#130'>SECTION&nbsp;4.17.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#130'>Personnel Matters</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>23</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#131'>SECTION&nbsp;4.18.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#131'>Environmental Matters</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>24</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#132'>SECTION&nbsp;4.19.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#132'>Intellectual Property</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>25</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#133'>SECTION&nbsp;4.20.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#133'>Regulatory Matters</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>27</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#134'>SECTION&nbsp;4.21.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#134'>Material Contracts</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>29</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#135'>SECTION&nbsp;4.22.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#135'><I>Opinion of Financial Advisors</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>30</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#136'>SECTION&nbsp;4.23.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#136'><I>Antitakeover Statutes and Rights
    Agreement</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>30</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#137'>SECTION&nbsp;4.24.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#137'><I>Hunter Data</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>30</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#138'>SECTION&nbsp;4.25.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#138'><I>Dynepo License</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>30</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;5<BR>
     </FONT>Representations and Warranties of Parent</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#139'>SECTION&nbsp;5.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#139'><I>Corporate Existence and Power</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>31</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#140'>SECTION&nbsp;5.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#140'><I>Corporate Authorization</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>31</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#141'>SECTION&nbsp;5.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#141'><I>Governmental Authorization</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>32</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#142'>SECTION&nbsp;5.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#142'><I>Non-contravention</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>32</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#143'>SECTION&nbsp;5.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#143'><I>Disclosure Documents</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>33</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#144'>SECTION&nbsp;5.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#144'><I>Finders&#146; Fees</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>33</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#145'>SECTION&nbsp;5.07.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#145'><I>Financing</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>33</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#146'>SECTION&nbsp;5.08.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#146'><I>Interested Stockholder</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>33</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;6<BR>
     </FONT>Covenants of the Company</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#147'>SECTION&nbsp;6.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#147'><I>Conduct of the Company</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>34</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#148'>SECTION&nbsp;6.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#148'><I>Stockholder Meeting; Proxy
    Material</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>36</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#149'>SECTION&nbsp;6.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#149'><I>No Solicitation; Other Offers</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>36</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#150'>SECTION&nbsp;6.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#150'><I>Access to Information</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>38</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#151'>SECTION&nbsp;6.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#151'><I>Voting of Shares of Parent Capital
    Stock</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>38</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#152'>SECTION&nbsp;6.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#152'><I>Notices of Certain Events</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>39</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;7<BR>
     </FONT>Covenants of Parent</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#153'>SECTION&nbsp;7.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#153'><I>Shareholder Meeting</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>39</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#154'>SECTION&nbsp;7.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#154'><I>Obligations of Merger Subsidiary</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>40</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#155'>SECTION&nbsp;7.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#155'><I>Voting of Shares</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>40</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#156'>SECTION&nbsp;7.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#156'><I>Director and Officer Liability</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>40</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#157'>SECTION&nbsp;7.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#157'><I>Employee Matters</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>41</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#158'>SECTION&nbsp;7.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#158'><I>Conduct of Parent</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>42</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>
</CENTER>

<P align="center" style="font-size: 10pt;">ii

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; ">

<TR style="font-size: 1pt;">
    <TD width="19%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<TR style="font-size: 8pt;">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center" nowrap><B>Page</B></TD><TD></TD>
</TR>

<TR valign="bottom" style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD><TD></TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;8<BR>
     </FONT>Covenants of Parent and the Company</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#159'>SECTION&nbsp;8.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#159'><I>Reasonable Best Efforts</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>42</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#160'>SECTION&nbsp;8.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#160'><I>Certain Filings</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>43</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#161'>SECTION&nbsp;8.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#161'><I>Public Announcements</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>43</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#162'>SECTION&nbsp;8.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#162'>Further Assurances</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>43</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#163'>SECTION&nbsp;8.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#163'><I>Employee Communications</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>44</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#164'>SECTION&nbsp;8.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#164'><I>Amendments to Dynepo License
    Agreement</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>44</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;9<BR>
     </FONT>Conditions to the Merger</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#165'>SECTION&nbsp;9.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#165'><I>Conditions to Obligations of Each
    Party</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>44</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#166'>SECTION&nbsp;9.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#166'>Conditions to the Obligations of Parent
    and Merger Subsidiary</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>45</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#167'>SECTION&nbsp;9.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    &nbsp;<A HREF='#167'><I>Conditions to the Obligations of the
    Company</I></A></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>45</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;10<BR>
     </FONT>Termination</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#168'>SECTION&nbsp;10.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#168'>Termination</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>46</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#169'>SECTION&nbsp;10.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#169'>Effect of Termination</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>48</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="7" align="center" valign="top">
    <FONT style="font-variant:SMALL-CAPS">ARTICLE&nbsp;11<BR>
     </FONT>Miscellaneous</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#170'>SECTION&nbsp;11.01.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#170'>Notices</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>48</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#171'>SECTION&nbsp;11.02.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#171'>Survival of Representations and
    Warranties</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>49</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#172'>SECTION&nbsp;11.03.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#172'>Amendments and Waivers</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>50</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#173'>SECTION&nbsp;11.04.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#173'>Expenses</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>50</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#174'>SECTION&nbsp;11.05.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#174'>Binding Effect; Benefit; No Third Party
    Beneficiaries; Assignment</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>51</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#175'>SECTION&nbsp;11.06.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#175'>Governing Law</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>52</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#176'>SECTION&nbsp;11.07.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#176'>Jurisdiction</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>52</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#177'>SECTION&nbsp;11.08.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#177'>WAIVER OF JURY TRIAL</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>52</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#178'>SECTION&nbsp;11.09.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#178'>Counterparts; Effectiveness</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>52</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#179'>SECTION&nbsp;11.10.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#179'>Entire Agreement</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>53</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#180'>SECTION&nbsp;11.11.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#180'>Severability</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>53</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    <FONT style="font-variant:SMALL-CAPS">&nbsp;<A HREF='#181'>SECTION&nbsp;11.12.</A></FONT></DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
    <I>&nbsp;<A HREF='#181'>Specific Performance</A></I></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom" nowrap>53</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left" style="font-size: 10pt;">
<!-- /TOC -->
</DIV>

<P align="center" style="font-size: 10pt;">iii

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
AGREEMENT AND PLAN OF MERGER (this <B>&#147;Agreement&#148;</B>)
dated as of April&nbsp;21, 2005, among Transkaryotic Therapies,
Inc., a Delaware corporation (the <B>&#147;Company&#148;</B>),
Shire Pharmaceuticals Group plc, a public limited company
incorporated under the laws of England and Wales
<B>(&#147;Parent&#148;)</B>, and Sparta Acquisition Corporation,
a Delaware corporation and a wholly-owned subsidiary of Parent
<B>(&#147;Merger Subsidiary&#148;</B>).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
WITNESSETH:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
WHEREAS, the respective Boards of Directors of the Company,
Parent and Merger Subsidiary have approved and deemed it
advisable that the respective stockholders of the Company,
Parent and Merger Subsidiary approve and adopt this Agreement
pursuant to which, among other things, Parent would acquire the
Company by means of a merger of Merger Subsidiary with and into
the Company on the terms and subject to the conditions set forth
in this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
WHEREAS, simultaneously with the execution and delivery of this
Agreement, Parent and the Company are entering into an agreement
(the <B>&#147;Dynepo License Agreement&#148;</B>) with respect
to the manufacturing, distribution and sale of the
gene-activated pharmaceutical composition of erthyropoietin
<B>(&#147;Dynepo&#148;)</B> outside of North America;&nbsp;and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
WHEREAS, simultaneously with the execution and delivery of this
Agreement, Parent, on the one hand, and Warburg, Pincus Equity
Partners, L.P., Warburg Pincus&nbsp;&#38; Co. and certain of
their Affiliates, on the other hand, are entering into an
agreement (the <B>&#147;Voting Agreement&#148;</B> and, together
with this Agreement and the Dynepo License Agreement, the
<B>&#147;Transaction Agreements&#148;</B>) pursuant to which
such stockholders will agree to take specified actions in
furtherance of the Merger;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
NOW, THEREFORE, in consideration of the foregoing and the
representations, warranties, covenants and agreements herein
contained, the parties hereto agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;1
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Definitions
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='101'></A>
</DIV>

<!-- link1 "Section 1.01. Definitions." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;1.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Definitions.</I>
(a)&nbsp;The following terms, as used herein, have the following
meanings:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Acquisition Proposal&#148;</B> means, other than the
    transactions contemplated by this Agreement, any Third Party
    offer, proposal or inquiry relating to, or any Third Party
    indication of interest in, (i)&nbsp;any acquisition or purchase,
    direct or <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    indirect, of 20% or more of the consolidated assets of the
    Company and its Subsidiaries or over 20% of any class of equity
    or voting securities of the Company, (ii)&nbsp;any tender offer
    (including a self-tender offer) or exchange offer that, if
    consummated, would result in any Third Party&#146;s beneficially
    owning 20% or more of any class of equity or voting securities
    of the Company or any of its Subsidiaries whose assets,
    individually or in the aggregate, constitute more than 20% of
    the consolidated assets of the Company or (iii)&nbsp;a merger,
    consolidation, share exchange, business combination, sale of
    substantially all the assets, reorganization, recapitalization,
    liquidation, dissolution or other similar transaction involving
    the Company or any of its Subsidiaries whose assets,
    individually or in the aggregate, constitute more than 20% of
    the consolidated assets of the Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Affiliate&#148;</B> means, with respect to any Person,
    any other Person directly or indirectly controlling, controlled
    by or under common control with such Person.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;AIM Study&#148;</B> means the clinical trial evaluating
    the use of Iduronate-2-Sulfatase for Hunter syndrome entitled
    the &#147;Assessment of I2S in MPS&nbsp;II.&#148;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Balance Sheet&#148;</B> means the consolidated balance
    sheet of the Company and its Subsidiaries as of
    December&nbsp;31, 2004 and the footnotes thereto set forth in
    the Company 10-K.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Balance Sheet Date&#148;</B> means December&nbsp;31,
    2004.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Business Day&#148;</B> means a day other than Saturday,
    Sunday or other day on which commercial banks in New York, New
    York are authorized or required by law to close.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Code&#148;</B> means the Internal Revenue Code of 1986.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Company Disclosure Schedule&#148;</B> means the Company
    disclosure schedule delivered to Parent by the Company
    concurrently herewith.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Company Employee Plan&#148;</B> means any Employee Plan
    that is maintained, administered, sponsored by or contributed to
    by the Company, any of its Subsidiaries or any of their
    respective ERISA Affiliates or with respect to which the Company
    or any of its Subsidiaries has any liability and that covers
    current or former directors or employees of the Company or any
    of its Subsidiaries.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Company International Plan&#148;</B> means any
    International Plan that is maintained, administered, sponsored
    by or contributed to by the Company or any of its Subsidiaries
    or with respect to which the Company or any of its Subsidiaries
    has any liability and that covers current or former directors or
    employees of the Company or any of its Subsidiaries.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">2

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Company Material Adverse Effect&#148;</B> means a
    material adverse effect on the financial condition, business,
    assets or results of operations of the Company and its
    Subsidiaries, taken as a whole, or on the Company&#146;s ability
    to consummate the transactions contemplated by this Agreement,
    excluding any such effect arising out of or resulting from
    (i)&nbsp;changes or conditions generally affecting the
    industries in which the Company and its Subsidiaries operate and
    not disproportionately affecting the Company and its
    Subsidiaries, (ii)&nbsp;changes in general economic or business
    conditions affecting any region in which the Company has a
    substantial presence, (iii)&nbsp;the public announcement or
    disclosure of (x)&nbsp;the Transaction Agreements or
    (y)&nbsp;the consummation or proposed consummation of the
    transactions contemplated by the Transaction Agreements,
    (iv)&nbsp;the results of the AIM Study, (v)&nbsp;the taking of
    (x)&nbsp;any action contemplated by this Agreement or
    (y)&nbsp;any action to which Parent shall have consented in
    writing, (vi)&nbsp;any failure, in and of itself, by the Company
    to meet any projections, forecasts or revenue or earnings
    predictions made public or provided by the Company in writing to
    Parent prior to the date hereof (it being understood that the
    facts or occurrences giving rise or contributing to such failure
    may be deemed to constitute, or be taken into account in
    determining whether there has been or is reasonably likely to be
    a Company Material Adverse Effect) and (vii)&nbsp;changes in
    laws of general application or interpretations thereof by courts
    or other governmental entities.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Company 10-K&#148;</B> means the Company&#146;s annual
    report on Form&nbsp;10-K for the fiscal year ended
    December&nbsp;31, 2004.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Delaware Law&#148;</B> means the General Corporation
    Law of the State of Delaware.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Employee Plan&#148;</B> means, written or otherwise,
    any (x)&nbsp;&#147;employee benefit plan&#148;, as defined in
    Section&nbsp;3(3) of ERISA, (y)&nbsp;employment, severance or
    similar service agreement, plan, arrangement or policy or any
    other plan or arrangement providing for compensation, bonuses,
    profit-sharing, stock option or other equity-based rights or
    other forms of incentive or deferred compensation, vacation
    benefits, insurance (including any self-insured arrangements),
    medical, dental or vision benefits, disability or sick leave
    benefits, life insurance, employee assistance program,
    workers&#146; compensation, supplemental unemployment benefits,
    severance benefits and post-employment or retirement benefits
    (including compensation, pension or insurance benefits), or
    (z)&nbsp;loan; in each case covering or extended to any current
    or former director or employee; <I>provided </I>that any
    International Plan (and any plan or program that would otherwise
    constitute an International Plan, but for the proviso in the
    definition of such term) shall not constitute an Employee Plan.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Environmental Laws&#148;</B> means any federal, state,
    local or foreign law (including common law), treaty, judicial
    decision, regulation, rule, judgment, order, decree, injunction,
    permit or governmental restriction or requirement or any
    agreement by the Company with any governmental authority,
    relating to the <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">3

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    protection, investigation or restoration of human health and
    safety, environment or to pollutants, contaminants, wastes or
    chemicals or any toxic, radioactive, ignitable, corrosive,
    reactive or otherwise hazardous substances, wastes or materials.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Environmental Permits&#148;</B> means all permits,
    licenses, franchises, certificates, approvals and other similar
    authorizations of governmental authorities required by
    Environmental Laws for the Company or any of its Subsidiaries to
    conduct its business.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;ERISA&#148;</B> means the Employee Retirement Income
    Security Act of 1974.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;ERISA Affiliate&#148;</B> of any entity means any other
    entity that, together with such entity, would be treated as a
    single employer under Section&nbsp;414 of the Code.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;HSR Act&#148;</B> means the Hart-Scott-Rodino
    Antitrust&nbsp;Improvements Act of 1976.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Intellectual Property Rights&#148;</B> means
    inventions, whether or not patentable, reduced to practice or
    made the subject of one or more pending patent applications,
    national and multinational statutory invention registrations,
    patents and patent applications (including all reissues,
    divisions, continuations, continuations-in-part, extensions and
    reexaminations thereof) registered or applied for in the United
    States and all other nations throughout the world, all
    improvements to the inventions disclosed in each such
    registration, patent or patent application, trademarks, service
    marks, trade dress, logos, domain names, trade names and
    corporate names (whether or not registered) in the United States
    and all other nations throughout the world, including all
    registrations and applications for registration of the foregoing
    and all goodwill associated therewith, copyrights (whether or
    not registered) and registrations and applications for
    registration thereof in the United States and all other nations
    throughout the world, including all derivative works, moral
    rights, renewals, extensions, reversions or restorations
    associated with such copyrights, now or hereafter provided by
    law, regardless of the medium of fixation or means of
    expression, trade secrets and, whether or not confidential, and
    know-how (including manufacturing and production processes and
    techniques and research and development information), copies and
    tangible embodiments of any of the foregoing, in whatever form
    or medium, all rights to obtain and rights to apply for patents,
    and to register trademarks and copyrights and all rights in all
    of the foregoing provided by treaties, conventions and common
    law.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;International Plan&#148;</B> means, whether or not
    statutorily required, any (x)&nbsp;employment, severance or
    similar service agreement, plan, arrangement or policy;
    (y)&nbsp;any other plan or arrangement providing for
    compensation, bonuses, profit-sharing, stock option or other
    equity-related rights or other forms of incentive or deferred
    compensation, vacation benefits, insurance (including any
    self-insured arrangements), medical, dental or vision benefits,
    disability or sick <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">4

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    leave benefits, life insurance, employee assistance program,
    workers&#146; compensation, supplemental unemployment benefits,
    severance benefits and post-employment or retirement benefits
    (including compensation, pension or insurance benefits); or
    (z)&nbsp;loan; in each case covering or extended to any current
    or former director or employee, where such individuals are
    located exclusively outside of the United States; <I>provided
    </I>that a plan or program sponsored or operated by a
    governmental authority (including the State Earnings Related
    Pension Scheme in the United Kingdom) shall not constitute an
    International Plan.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Knowledge&#148;</B> of (a)&nbsp;the Company or any of
    its Subsidiaries means the knowledge of any of the individuals
    set forth in Section&nbsp;1.01 of the Company Disclosure
    Schedule and (b)&nbsp;Parent or any of its Subsidiaries means
    the knowledge of the Chief Executive Officer, Chief Operating
    Officer, Chief Financial Officer or General Counsel or any
    senior officer responsible for each functional area of Parent.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Licensed Intellectual Property Rights&#148;</B> means
    all Intellectual Property Rights owned by a Third Party and
    licensed or sublicensed to the Company or any of its
    Subsidiaries.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Lien&#148;</B> means, with respect to any property or
    asset, any mortgage, lien, pledge, charge, security interest, or
    other encumbrance of any kind in respect of such property or
    asset. For purposes of this Agreement, a Person shall be deemed
    to own subject to a Lien, any property or asset that it has
    acquired or holds subject to the interest of a vendor or lessor
    under any conditional sale agreement, capital lease or other
    title retention agreement relating to such property or asset.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;1933&nbsp;Act&#148;</B> means the Securities Act of
    1933.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;1934&nbsp;Act&#148;</B> means the Securities Exchange
    Act of 1934.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Owned Intellectual Property Rights&#148;</B> means all
    Intellectual Property Rights owned by the Company or any of its
    Subsidiaries.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Parent Material Adverse Effect&#148;</B> means a
    material adverse effect on Parent&#146;s ability to consummate
    the transactions contemplated by this Agreement.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Person&#148;</B> means an individual, corporation,
    partnership, limited liability company, association, trust or
    other entity or organization, including a government or
    political subdivision or an agency or instrumentality thereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Qualifying Termination&#148;</B> means (a)&nbsp;a
    termination by either Parent or the Company pursuant to
    Section&nbsp;10.01(b)(iv), (b)&nbsp;a termination by the Company
    pursuant to Section&nbsp;10.01(f) or Section&nbsp;10.01(g) or
    (c)&nbsp;a termination by Parent pursuant to
    Section&nbsp;10.01(e) if Section&nbsp;4.24 is among the
    provisions alleged by Parent to have been breached.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">5

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Sarbanes-Oxley Act&#148;</B> means the Sarbanes-Oxley
    Act of 2002.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;SEC&#148;</B> means the Securities and Exchange
    Commission.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Shares&#148;</B> means the shares of common stock,
    $0.01&nbsp;par value, of the Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Subsidiary&#148;</B> means, with respect to any Person,
    any entity of which securities or other ownership interests
    having ordinary voting power to elect a majority of the board of
    directors or other persons performing similar functions are at
    any time directly or indirectly owned by such Person.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Third Party&#148;</B> means any Person other than
    Parent or any of its Affiliates and their respective advisors
    and agents (acting in such capacity).</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;Each of the following terms is defined in the Section
set forth opposite such term:
</DIV>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; margin-top: 12pt; ">

<TR style="font-size: 1pt;">
    <TD width="86%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
</TR>

<TR style="font-size: 8pt;">
    <TD align="center" nowrap><B>Term</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" nowrap><B>Section</B></TD>
</TR>

<TR valign="bottom" style="font-size: 1px">
    <TD align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Adverse Recommendation Change</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    6.02</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Agreement</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Preamble</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Certificates</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.03</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Change in Parent Recommendation</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    7.01</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Closing Date</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.01</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Preamble</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Payment Event</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    11.04</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Proxy Statement</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.10</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company SEC Documents</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.07</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Securities</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Stock Option</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.05</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Stock Plan</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Stockholder Approval</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.02</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Stockholder Meeting</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    6.02</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Company Subsidiary Securities</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.06</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Competing Proposal</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    10.01</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Confidentiality Agreement</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    6.03</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Continuing Employee</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    7.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Continuing Employee Plans</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    7.05</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Current SEC Documents</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.12</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Dynepo</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Recitals</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Dynepo License Agreement</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Recitals</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Effective Time</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.01</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    End Date</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    10.01</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Exchange Agent</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.03</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Exchange Ratio</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    FDA</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.20</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    GAAP</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.08</TD>
</TR>

</TABLE>
</CENTER>

<P align="center" style="font-size: 10pt;">6

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; ">

<TR style="font-size: 1pt;">
    <TD width="86%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
</TR>

<TR style="font-size: 8pt;">
    <TD align="center" nowrap><B>Term</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" nowrap><B>Section</B></TD>
</TR>

<TR valign="bottom" style="font-size: 1px">
    <TD align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" nowrap style="border-top: 1pt solid #000000;">&nbsp;</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Hunter Data</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.24</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    I2S</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.24</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Indemnified Person</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    7.04</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Key Product</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.21</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    License Agreement</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.19</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Material Contract</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.21</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Merger</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.01</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Merger Consideration</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.02</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Merger Subsidiary</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Preamble</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    New Offer</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    10.01</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Parent</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Preamble</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Parent Payment Event</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    11.04</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Parent Share</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.05</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Parent Shareholder Circular</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    5.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Parent Shareholder Meeting</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    7.01</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Preferred Stock</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Product Contract</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.21</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Specified Stock Option</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    6.01</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Substituted Stock Option</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.05</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Substitution Premium</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.05</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Superior Proposal</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    6.03</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Surviving Corporation</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    2.01</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Tax</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.16</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Tax Return</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.16</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Taxing Authority</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.16</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Transaction Agreements</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Recitals</TD>
</TR>

<TR valign="bottom" bgcolor="#cceeff">
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Voting Agreement</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    Recitals</TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left: 10px; text-indent: -10px">
    Warn Act</DIV>
    </TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">
    4.17</TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='102'></A>
</DIV>

<!-- link1 "Section 1.02." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;1.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Other
Definitional And Interpretative Provisions.</I> Unless specified
otherwise, in this Agreement the obligations of any party
consisting of more than one person are joint and several. The
words &#147;hereof&#148;, &#147;herein&#148; and
&#147;hereunder&#148; and words of like import used in this
Agreement shall refer to this Agreement as a whole and not to
any particular provision of this Agreement. The captions herein
are included for convenience of reference only and shall be
ignored in the construction or interpretation hereof. References
to Articles, Sections, Exhibits and Schedules are to Articles,
Sections, Exhibits and Schedules of this Agreement unless
otherwise specified. Any capitalized terms used in any Exhibit
or Schedule but not otherwise defined therein, shall have the
meaning as defined in this Agreement. Any singular term in this
Agreement shall be deemed to include the plural, and any plural
term the singular. Whenever the words &#147;include&#148;,
&#147;includes&#148; or &#147;including&#148; are used in this
Agreement, they shall be deemed to be followed by the words
&#147;without limitation&#148;, whether or not they are in fact
followed by those words or words of like import.
&#147;Writing&#148;, &#147;written&#148; and comparable terms
refer to printing, typing and other means of reproducing words
<BR>
</DIV>

<P align="center" style="font-size: 10pt;">7

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
(including electronic media) in a visible form. References to
any statute are to that statute, as amended from time to time,
and to the rules and regulations promulgated thereunder.
References to any agreement or contract are to that agreement or
contract as amended, modified or supplemented from time to time
in accordance with the terms hereof and thereof; <I>provided
</I>that with respect to any agreement or contract listed on any
Schedule hereto, all such amendments, modifications or
supplements must also be listed in the appropriate Schedule.
References to any Person include the successors and permitted
assigns of that Person. References from or through any date
mean, unless otherwise specified, from and including or through
and including, respectively. References to &#147;law&#148;,
&#147;laws&#148; or to a particular statute or law shall be
deemed also to include any and all related rules, regulations,
ordinances, directives, treaties and judicial or administrative
decisions, judgments, decrees or injunctions of any U.S.&nbsp;or
non-U.S.&nbsp;federal, state, local or foreign governmental
authority. References to any U.S.&nbsp;legal term shall, with
respect to any jurisdiction other than the United States or any
state or territory thereof, be construed as references to the
term or concept which most nearly corresponds to it in that
jurisdiction.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;2
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">The Merger
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='103'></A>
</DIV>

<!-- link1 "Section 2.01." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
Merger.</I> (a)&nbsp;Subject to the terms and conditions of this
Agreement, at the Effective Time, Merger Subsidiary shall be
merged (the <B>&#147;Merger&#148;</B>) with and into the Company
in accordance with Delaware Law, whereupon the separate
existence of Merger Subsidiary shall cease, and the Company
shall be the surviving corporation (the <B>&#147;Surviving
Corporation&#148;</B>).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;The closing of the Merger shall take place at the
offices of Davis Polk&nbsp;&#38; Wardwell, 450 Lexington Avenue,
New York, New York as soon as practicable following the
satisfaction or, to the extent permitted hereunder, waiver (by
the party or parties entitled to the benefits thereof) of all
conditions to the Merger (other than any condition that by its
nature cannot be satisfied until the closing of the Merger, but
subject to satisfaction of such condition), or at such other
place, date and time as may be agreed by the parties. The date
on which the closing of the Merger occurs is referred to in this
Agreement as the <B>&#147;Closing Date&#148;</B>. The parties
shall prepare and on the Closing Date shall file with the
Secretary of State of the State of Delaware a certificate of
merger or other appropriate documents executed in accordance
with the relevant provisions of Delaware Law and shall make all
other filings or recordings required under Delaware Law. The
Merger shall become effective at such time (the
<B>&#147;Effective Time&#148;</B>) as the certificate of merger
is duly filed with the Delaware Secretary of State (or at such
later time as Parent and the Company shall agree and is
specified in the certificate of merger).
</DIV>

<P align="center" style="font-size: 10pt;">8

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(c)&nbsp;The Merger shall have the effects set forth in
Section&nbsp;259 of the Delaware Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='104'></A>
</DIV>

<!-- link1 "Section 2.02." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Conversion
of Shares.</I> At the Effective Time,
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;except as otherwise provided in Section&nbsp;2.02(b) or
    Section&nbsp;2.04, each Share outstanding immediately prior to
    the Effective Time shall be converted into the right to receive
    $37.00 in cash, without interest (the <B>&#147;Merger
    Consideration&#148;</B>);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;each Share held by the Company as treasury stock or
    owned by Parent or any of its wholly-owned Subsidiaries
    immediately prior to the Effective Time shall be canceled, and
    no payment shall be made with respect thereto;&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;each share of common stock of Merger Subsidiary
    outstanding immediately prior to the Effective Time shall be
    converted into and become one share of common stock, par value
    $0.01&nbsp;per share, of the Surviving Corporation and shall
    constitute the only outstanding shares of capital stock of the
    Surviving Corporation.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='105'></A>
</DIV>

<!-- link1 "Section 2.03." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Surrender
and Payment.</I> (a)&nbsp;Prior to the Effective Time, Parent
shall appoint a bank or trust company, reasonably acceptable to
the Company (the <B>&#147;Exchange Agent&#148;</B>), for the
purpose of exchanging certificates that immediately prior to the
Effective Time represented Shares that were converted into the
right to receive the Merger Consideration pursuant to
Section&nbsp;2.02(a) (the <B>&#147;Certificates&#148;</B>) for
the Merger Consideration, and Parent and Exchange Agent shall
enter into an exchange agreement which shall, in form and
substance, be reasonably acceptable to the Company. Parent
shall, on and from time to time after the Effective Date, make
available to the Exchange Agent, as needed, the Merger
Consideration to be paid in respect of the Certificates. As
promptly as practicable after the Effective Time, Parent shall
send, or shall cause the Exchange Agent to send, to each holder
of Certificates a letter of transmittal and instructions (which
shall specify that the delivery shall be effected, and risk of
loss and title shall pass, only upon proper delivery of the
Certificates to the Exchange Agent and shall be reasonably
acceptable to the Company) for use in such exchange.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;Each holder of Shares that have been converted into the
right to receive the Merger Consideration pursuant to
Section&nbsp;2.02(a) shall be entitled to receive, upon
surrender to the Exchange Agent of a Certificate, together with
a properly completed letter of transmittal, the Merger
Consideration payable for each Share formerly represented by a
Certificate. Until so surrendered or transferred, as the case
may be, each such Certificate shall represent after the
Effective Time for all purposes only the right to receive such
Merger Consideration.
</DIV>

<P align="center" style="font-size: 10pt;">9

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(c)&nbsp;If any portion of the Merger Consideration is to be
paid to a Person other than the Person in whose name the
surrendered Certificate is registered, it shall be a condition
to such payment that (i)&nbsp;either such Certificate shall be
properly endorsed or shall otherwise be in proper form for
transfer and (ii)&nbsp;the Person requesting such payment shall
pay to the Exchange Agent any transfer or other taxes required
as a result of such payment to a Person other than the
registered holder of such Certificate or establish to the
satisfaction of the Exchange Agent that such tax has been paid
or is not payable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(d)&nbsp;After the Effective Time, there shall be no further
registration of transfers of Shares. If, after the Effective
Time, Certificates are presented to the Surviving Corporation,
they shall be canceled and exchanged for the Merger
Consideration provided for, and in accordance with the
procedures set forth, in this Article&nbsp;2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(e)&nbsp;Any portion of the Merger Consideration made available
to the Exchange Agent pursuant to Section&nbsp;2.03(a) (and any
interest and other income earned thereon) that remains unclaimed
by the holders of Certificates six months after the Effective
Time shall be returned to the Surviving Corporation, upon
demand, and any such holder who has not exchanged such
Certificate for the Merger Consideration in accordance with this
Section&nbsp;2.03 prior to that time shall thereafter look only
to the Surviving Corporation for payment of the Merger
Consideration in respect of such Shares without any interest
thereon. Notwithstanding the foregoing, neither Parent nor the
Surviving Corporation shall be liable to any holder of Shares
for any amount paid to a public official pursuant to applicable
abandoned property, escheat or similar laws. Any amounts
remaining unclaimed by holders of Shares two years after the
Effective Time (or such earlier date immediately prior to such
time when the amounts would otherwise escheat to or become
property of any governmental authority) shall become, to the
extent permitted by applicable law, the property of the
Surviving Corporation free and clear of any claims or interest
of any Person previously entitled thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(f)&nbsp;Any portion of the Merger Consideration made available
to the Exchange Agent pursuant to Section&nbsp;2.03(a) to pay
for Shares for which appraisal rights have been perfected shall
be returned to the Surviving Corporation, upon demand.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='106'></A>
</DIV>

<!-- link1 "Section 2.04." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Dissenting
Shares.</I> Notwithstanding Section&nbsp;2.02, Shares which are
issued and outstanding immediately prior to the Effective Time
and held by a holder who has not voted such Shares in favor of
the Merger or consented thereto in writing and who has demanded
appraisal for such Shares in accordance with Section&nbsp;262 of
the Delaware Law shall not be converted into the right to
receive the Merger Consideration, unless such holder fails to
perfect, withdraws or loses the right to appraisal. If, after
the Effective Time, such holder fails to perfect, withdraws or
loses the right to appraisal, such Shares shall be treated as if
they had been converted as of the Effective Time into the right
to <BR>
</DIV>

<P align="center" style="font-size: 10pt;">10

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
receive the Merger Consideration. The Company shall give Parent
prompt notice of any demands received by the Company for
appraisal of Shares, and Parent shall have the right to
participate in all negotiations and proceedings with respect to
such demands. Except with the prior written consent of Parent,
the Company shall not make any payment with respect to, or offer
to settle or settle, any such demands.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='107'></A>
</DIV>

<!-- link1 "Section 2.05." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Company
Stock Options.</I> (a)&nbsp;Except as provided in
Section&nbsp;2.05(b), each option (a <B>&#147;Company Stock
Option&#148;</B>) to purchase Shares granted under an equity
compensation plan or arrangement of the Company (a
<B>&#147;Company Stock Plan&#148;</B>), whether vested or
unvested, that is outstanding immediately prior to the Effective
Time shall be canceled as of the Effective Time, and in
consideration therefor the Company shall pay the holder of such
Company Stock Option at the Effective Time an amount in cash
equal to the product of (i)&nbsp;the excess, if any, of $37.00
over the applicable exercise price per Share of such Company
Stock Option multiplied by (ii)&nbsp;the number of Shares such
holder could have purchased (assuming full vesting of such
Company Stock Option) had such holder exercised such Company
Stock Option in full immediately prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;(i)&nbsp;Each Specified Stock Option, whether vested or
unvested, that is outstanding immediately prior to the Effective
Time shall be canceled as of the Effective Time, and in
substitution therefor Parent shall, as soon as reasonably
practicable following the Effective Time (<I>i.e.</I>, during
the next available time that is not a &#147;closed period&#148;
under applicable law or Parent&#146;s company policy), provide
to the holder of such Specified Stock Option a stock option of
equivalent value under an equity compensation plan of Parent
then in effect (a <B>&#147;Substituted Stock Option&#148;</B>).
A Substituted Stock Option shall be deemed to have value
equivalent to the applicable Specified Stock Option if
(x)&nbsp;the exercise price of such Substituted Stock Option is
calculated pursuant to the rules of Parent&#146;s scheme for
substituted grants on the date of grant of such Substituted
Stock Option and (y)&nbsp;the number of shares of Parent&#146;s
ordinary shares <B>(&#147;Parent Shares&#148;</B>) covered by
such Substituted Stock Option is equal to, as rounded down to
the nearest whole share, the product of the number of Shares
that the holder of such Specified Stock Option could have
purchased (assuming full vesting of such Specified Stock Option)
had such holder exercised such Specified Stock Option in full
immediately prior to the Effective Time <I>multiplied by </I>the
Exchange Ratio (as defined below), and further <I>multiplied
by</I> a Substitution Premium (as defined below). The
<B>&#147;Exchange Ratio&#148;</B> shall be a number (rounded to
the nearest ten-thousandth) determined by dividing the pound
sterling equivalent of $37.00 (using an exchange rate agreed
between Parent and the Company, as in effect on the date on
which the Effective Time occurs) <I>by</I> the average of the
closing sales prices of a Parent Share (expressed in pound
sterling at the same exchange rate) on the London Stock Exchange
during the five full trading days immediately preceding the date
on which the Effective Time occurs. The <B>&#147;Substitution
Premium&#148;</B> shall be a number greater than 1 that
Parent&#146;s Remuneration <BR>
</DIV>

<P align="center" style="font-size: 10pt;">11

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
Committee shall determine in its sole and reasonable discretion
prior to the Effective Time to take into account the fact that
Specified Stock Options would otherwise have vested over time,
whereas Substituted Stock Options will vest on the basis of
performance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(ii)&nbsp;At the Effective Time, Parent shall have effective a
registration statement on Form&nbsp;S-8 (or another appropriate
form) registering a number of Parent Shares equal to the number
of Parent Shares subject to the Substituted Stock Options. Such
registration statement shall be kept effective (and the current
status of the prospectus or prospectuses required thereby shall
be maintained) as long as any Substituted Stock Options may
remain outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(c)&nbsp;Prior to the Effective Time, the Company shall deliver
to the holders of Company Stock Options any required notices and
shall take any other required or appropriate action under the
terms of such Company Stock Plans, including (i)&nbsp;obtaining
any consents from such holders and (ii)&nbsp;making any
amendments to the terms of such Company Stock Plans, in each
case that are necessary to give effect to the transactions
contemplated by this Section&nbsp;2.05.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='108'></A>
</DIV>

<!-- link1 "Section 2.06." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Adjustments.</I>
If, during the period between the date of this Agreement and the
Effective Time, any change in the outstanding Shares shall
occur, including by reason of any reclassification,
recapitalization, stock split or combination, exchange or
readjustment of Shares, or stock dividend thereon with a record
date during such period the Merger Consideration and any other
amounts payable pursuant to this Agreement shall be
appropriately adjusted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='109'></A>
</DIV>

<!-- link1 "Section 2.07." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.07.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Withholding
Rights.</I> Each of the Surviving Corporation and Parent shall
be entitled to deduct and withhold from the consideration
otherwise payable to any Person pursuant to this Article&nbsp;2
such amounts as it is required to deduct and withhold with
respect to the making of such payment under any provision of
federal, state, local or foreign Tax law. If the Surviving
Corporation or Parent, as the case may be, so withholds amounts,
such amounts shall be treated for all purposes of this Agreement
as having been paid to the holder of the Shares, options or
warrants, as the case may be, in respect of which the Surviving
Corporation or Parent, as the case may be, made such deduction
and withholding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='110'></A>
</DIV>

<!-- link1 "Section 2.08." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;2.08.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Lost
Certificates.</I> If any Certificate shall have been lost,
stolen or destroyed, upon the making of an affidavit of that
fact by the Person claiming such Certificate to be lost, stolen
or destroyed and, if required by the Surviving Corporation, the
posting by such Person of a bond, in such reasonable amount as
the Surviving Corporation may direct, as indemnity against any
claim that may be made against it with respect to such
Certificate, the Exchange Agent shall pay, in exchange for such
lost, stolen or destroyed Certificate, the Merger Consideration
to be paid in respect of the Shares represented by such
Certificate, as contemplated by this Article&nbsp;2.
</DIV>

<P align="center" style="font-size: 10pt;">12

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;3
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">The Surviving Corporation
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='111'></A>
</DIV>

<!-- link1 "Section 3.01." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;3.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certificate
of Incorporation.</I> The certificate of incorporation of the
Company in effect at the Effective Time shall be the certificate
of incorporation of the Surviving Corporation until amended in
accordance with Delaware Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='112'></A>
</DIV>

<!-- link1 "Section 3.02." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;3.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Bylaws.</I>
The bylaws of the Company in effect at the Effective Time shall
be the bylaws of the Surviving Corporation until amended in
accordance with Delaware Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<A name='113'></A>
</DIV>

<!-- link1 "Section 3.03." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;3.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Directors
and Officers.</I> From and after the Effective Time, until
successors are duly elected or appointed and qualified in
accordance with Delaware Law, (i)&nbsp;the directors of Merger
Subsidiary at the Effective Time shall be the directors of the
Surviving Corporation and (ii)&nbsp;the officers of the Company
at the Effective Time shall be the officers of the Surviving
Corporation.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;4
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Representations and
Warranties of the Company
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Except as set forth in (i)&nbsp;the reports, schedules, forms,
statements and other documents filed by the Company with, or
furnished by the Company to, the SEC after January&nbsp;1, 2004
and publicly available prior to the date of this Agreement or
(ii)&nbsp;the Company Disclosure Schedule (with specific
reference to the Section or subsection of this Agreement to
which the information stated therein relates; <I>provided
</I>that information set forth in one Section or subsection of
the Company Disclosure Schedule shall be deemed to apply to each
other Section or subsection to which its relevance is readily
apparent on its face), the Company represents and warrants to
Parent that:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='114'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.01." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Corporate
Existence and Power.</I> The Company is a corporation duly
incorporated, validly existing and in good standing under the
laws of the State of Delaware and has all corporate powers and
all governmental licenses, authorizations, permits, consents and
approvals required to carry on its business as now conducted,
except for those licenses, authorizations, permits, consents and
approvals the absence of which is not reasonably likely to have,
individually or in the aggregate, a Company Material Adverse
Effect. The Company is duly qualified to do business as a
foreign corporation and is in good standing in each jurisdiction
where such qualification is necessary, except for those
jurisdictions where failure to be so qualified is not reasonably
likely to have, individually or in the aggregate, a Company
Material Adverse Effect. The Company has heretofore made
available to Parent true and complete copies of the certificate
of incorporation and bylaws of the Company as currently in
effect.
</DIV>

<P align="center" style="font-size: 10pt;">13

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='115'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.02." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Corporate
Authorization.</I> (a)&nbsp;The execution, delivery and
performance by the Company of the Transaction Agreements to
which it is a party and the consummation by the Company of the
transactions contemplated thereby are within the Company&#146;s
corporate powers and, except for obtaining the Company
Stockholder Approval in connection with the consummation of the
Merger, have been duly authorized by all necessary corporate
action on the part of the Company. Assuming the representation
in Section&nbsp;5.08 is true and correct, the adoption of this
Agreement by the holders of a majority of the outstanding Shares
(the <B>&#147;Company Stockholder Approval&#148;</B>) is the
only vote of the holders of any of the Company&#146;s capital
stock necessary in connection with the consummation of the
transactions contemplated by the Transaction Agreements. Each of
the Transaction Agreements to which it is a party constitutes a
valid and binding agreement of the Company, enforceable against
the Company in accordance with its terms, except (i)&nbsp;as the
same may be limited by applicable bankruptcy, insolvency,
reorganization, fraudulent conveyance, moratorium or similar
laws of general application relating to or affecting
creditors&#146; rights and (ii)&nbsp;for the limitations imposed
by general principles of equity (regardless of whether
considered in a proceeding at law or in equity).
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;At a meeting duly called and held, the Company&#146;s
    Board of Directors has (i)&nbsp;determined that the Transaction
    Agreements and the transactions contemplated thereby are fair to
    and in the best interest of the Company&#146;s stockholders,
    (ii)&nbsp;approved the Transaction Agreements and the
    transactions contemplated thereby, (iii)&nbsp;resolved to
    recommend adoption of this Agreement by its stockholders,
    (iv)&nbsp;declared this Agreement and the Merger advisable and
    (v)&nbsp;directed that this Agreement be submitted to a vote at
    a meeting of the Company&#146;s stockholders.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='116'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.03." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governmental
Authorization.</I> The execution, delivery and performance by
the Company of the Transaction Agreements to which it is a party
and the consummation by the Company of the transactions
contemplated thereby require no action by the Company by or in
respect of, or filing by the Company with, any governmental
body, agency, official or authority, domestic, foreign or
supranational, other than (i)&nbsp;the filing of a certificate
of merger with respect to the Merger with the Delaware Secretary
of State, (ii)&nbsp;compliance with any applicable requirements
of the HSR Act and any applicable competition, antitrust or
similar law of any jurisdiction outside the United States,
(iii)&nbsp;compliance with any applicable requirements of the
1934&nbsp;Act and the rules and regulations promulgated
thereunder, (iv)&nbsp;such consents, approvals, orders,
authorizations, registrations, declarations and filings as may
be required under applicable state securities laws and the
securities laws of any foreign country and (v)&nbsp;any actions
or filings the failure of which to take is not reasonably likely
to have, individually or in the aggregate, a Company Material
Adverse Effect. To the Knowledge of the Company, as of the date
of this Agreement, there is no material issue with regard to the
transactions contemplated by the Transaction Agreements under
the <BR>
</DIV>

<P align="center" style="font-size: 10pt;">14

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
HSR Act or any applicable competition, antitrust or similar law
of any jurisdiction outside the United States.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='117'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.04." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Non-contravention.</I>
The execution, delivery and performance by the Company of each
Transaction Agreement to which it is a party and the
consummation by the Company of the transactions contemplated
thereby do not and will not (i)&nbsp;contravene, conflict with
or result in any violation or breach of any provision of the
certificate of incorporation or bylaws of the Company,
(ii)&nbsp;assuming compliance with the matters referred to in
Section&nbsp;4.03, contravene, conflict with or result in a
violation or breach of any provision of any law, statute,
ordinance, rule, regulation, judgment, injunction, order or
decree applicable to the Company or any of its Subsidiaries,
(iii)&nbsp;require any consent or other action by any Person
under, constitute a default, or an event that, with or without
notice or lapse of time or both, would constitute a default,
under, or cause or permit the termination, cancellation,
acceleration or the loss of any material benefit to which the
Company or any of its Subsidiaries is entitled under any
provision of any agreement, other instrument, license,
franchise, permit, certificate, approval or other similar
authorization to which the Company or any of its Subsidiaries is
a party or by which any of their respective assets are bound or
(iv)&nbsp;result in the creation or imposition of any Lien on
any asset of the Company or any of its Subsidiaries, except in
the case of clauses&nbsp;(ii), (iii), and (iv)&nbsp;for such
contraventions, conflicts, violations or breaches, failures to
obtain any such consent or take any other action, defaults,
terminations, cancellations, accelerations, losses or Liens that
are not reasonably likely to have, individually or in the
aggregate, a Company Material Adverse Effect.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='118'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.05." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Capitalization.</I>
(a)&nbsp;The authorized capital stock of the Company consists of
(i)&nbsp;100,000,000&nbsp;Shares and
(ii)&nbsp;10,000,000&nbsp;shares of preferred stock,
$0.01&nbsp;par value per share (the <B>&#147;Preferred
Stock&#148;</B>), of which 1,000,000&nbsp;shares have been
designated Series&nbsp;B Preferred Stock. As of the close of
business on April&nbsp;15, 2005, there were outstanding
34,894,799&nbsp;Shares and no shares of Preferred Stock. As of
the close of business on April&nbsp;15, 2005, there were
outstanding Company Stock Options to purchase an aggregate of
6,383,731&nbsp;Shares (of which options to purchase an aggregate
of 5,384,682&nbsp;Shares had an exercise price equal to or less
than $37.00 and a weighted-average exercise price of $16.33).
Section&nbsp;4.05(a) of the Company Disclosure Schedule sets
forth a schedule of all outstanding Company Stock Options as of
the close of business on April&nbsp;15, 2005, including with
respect to each such Company Stock Option, the name of the
holder, the equity compensation plan under which it was granted,
whether the option is an incentive stock option or a
non-qualified stock option, the exercise price and the grant
date. All outstanding shares of capital stock of the Company
have been, and all Shares that may be issued upon exercise of
Company Stock Options will be when issued, duly authorized,
validly issued, fully paid and nonassessable. No Subsidiary of
the Company owns any shares of capital stock of the Company.
</DIV>

<P align="center" style="font-size: 10pt;">15

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;Except as set forth in this Section&nbsp;4.05 and for
    changes since March&nbsp;31, 2005 resulting from the exercise of
    Company Stock Options outstanding on such date, as of the date
    of this Agreement there are no outstanding (i)&nbsp;shares of
    capital stock of or other voting securities or ownership
    interests in the Company, (ii)&nbsp;securities of the Company
    convertible into or exchangeable for shares of capital stock or
    other voting securities or ownership interests in the Company or
    (iii)&nbsp;options or other rights to acquire from the Company,
    or other obligation of the Company to issue, any capital stock
    or other voting securities or ownership interests in or any
    securities convertible into or exchangeable for capital stock or
    other voting securities or ownership interests in the Company
    (the items in clauses&nbsp;(i), (ii)&nbsp;and (iii)&nbsp;being
    referred to collectively as the <B>&#147;Company
    Securities&#148;</B>). There are no outstanding obligations of
    the Company or any of its Subsidiaries to repurchase, redeem or
    otherwise acquire any of the Company Securities.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='119'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.06." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Subsidiaries.</I>
(a)&nbsp;Each Subsidiary of the Company is a corporation duly
incorporated, validly existing and in good standing (with
respect to jurisdictions that recognize such concept) under the
laws of its jurisdiction of incorporation, has all corporate
powers and all governmental licenses, authorizations, permits,
consents and approvals required to carry on its business as now
conducted, except for those licenses, authorizations, permits,
consents and approvals the absence of which are not reasonably
likely to have, individually or in the aggregate, a Company
Material Adverse Effect. Each such Subsidiary is duly qualified
to do business as a foreign corporation and is in good standing
in each jurisdiction (with respect to jurisdictions that
recognize such concept) where such qualification is necessary,
except for those jurisdictions where failure to be so qualified
is not reasonably likely to have, individually or in the
aggregate, a Company Material Adverse Effect. All Subsidiaries
of the Company and their respective jurisdictions of
incorporation are identified in Section&nbsp;4.06(a) of the
Company Disclosure Schedule.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;All of the outstanding capital stock of, or other
    voting securities or ownership interests in, each Subsidiary of
    the Company is owned by the Company, directly or indirectly,
    free and clear of any Lien and free of any other limitation or
    restriction (including any restriction on the right to vote,
    sell or otherwise dispose of such capital stock or other voting
    securities or ownership interests). There are no outstanding
    (i)&nbsp;securities of the Company or any of its Subsidiaries
    convertible into or exchangeable for shares of capital stock of
    or other voting securities or ownership interests in any
    Subsidiary of the Company or (ii)&nbsp;options or other rights
    to acquire from the Company or any of its Subsidiaries, or other
    obligation of the Company or any of its Subsidiaries to issue,
    any capital stock of or other voting securities or ownership
    interests in, or any securities convertible into or exchangeable
    for any capital stock of or other voting securities or ownership
    interests in, any Subsidiary of the Company (the items in
    clauses&nbsp;(i) and (ii)&nbsp;being referred to collectively as
    the <B>&#147;Company Subsidiary Securities&#148;</B>). There are
    no outstanding obligations of the Company or any of its
    Subsidiaries to <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">16

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    repurchase, redeem or otherwise acquire any of the Company
    Subsidiary Securities.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='120'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.07." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.07.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>SEC
Filings; Sarbanes-Oxley Act.</I> (a)&nbsp;The Company has made
available to Parent true and complete copies of (i)&nbsp;the
Company&#146;s annual reports on Form&nbsp;10-K for its fiscal
years ended December&nbsp;31, 2004 and 2003, (ii)its proxy or
information statements relating to meetings of the stockholders
of the Company held (or actions taken without a meeting by such
stockholders) since January&nbsp;1, 2003 and (iii)&nbsp;all of
its other reports, statements, schedules and registration
statements filed with the SEC since December&nbsp;31, 2003 (the
documents referred to in the foregoing clauses&nbsp;(i)-(iii),
collectively, the <B>&#147;Company SEC Documents&#148;</B>). The
Company has made available to Parent true and complete copies of
all comment letters from the staff of the SEC relating to the
Company SEC Documents and all written responses of the Company
thereto.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;As of its filing date, each Company SEC Document
    complied, and each such Company SEC Document filed subsequent to
    the date hereof will comply, as to form in all material respects
    with the applicable requirements of the 1933&nbsp;Act and the
    1934&nbsp;Act, as the case may be.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;As of its filing date (or, if amended or superseded by
    a filing prior to the date hereof, on the date of such filing),
    each Company SEC Document filed pursuant to the 1934&nbsp;Act
    did not, and each such Company SEC Document filed subsequent to
    the date hereof will not, contain any untrue statement of a
    material fact or omit to state any material fact required to be
    stated therein or necessary to make the statements made therein,
    in the light of the circumstances under which they were made,
    not misleading.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;Each Company SEC Document that is a registration
    statement, as amended or supplemented, if applicable, filed
    pursuant to the 1933&nbsp;Act, as of the date such registration
    statement or any post-effective amendment thereto became
    effective, did not contain any untrue statement of a material
    fact or omit to state any material fact required to be stated
    therein or necessary to make the statements therein not
    misleading.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;Each Company SEC Document that was required to be
    accompanied by the certifications required to be filed or
    submitted by the Company&#146;s principal executive officer and
    principal financial officer pursuant to the Sarbanes-Oxley Act
    was accompanied by such certification and, at the time of filing
    or submission of each such certification, such certification was
    true and accurate and complied with the Sarbanes-Oxley Act.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;There are no outstanding loans made by the Company or
    any of its Subsidiaries to any executive officer (as defined in
    Rule&nbsp;3b-7 under the 1934&nbsp;Act) or director of the
    Company. The Company has not since the enactment of the
    Sarbanes-Oxley Act, taken any action prohibited by
    Section&nbsp;402 of the Sarbanes-Oxley Act.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">17

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='121'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.08." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.08.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Financial
Statements.</I> The audited consolidated financial statements
and unaudited consolidated interim financial statements of the
Company included in the Company SEC Documents fairly present, in
conformity with generally accepted accounting principles in the
United States <B>(&#147;GAAP&#148;</B>) applied on a consistent
basis (except as may be indicated in the notes thereto), the
consolidated financial position of the Company and its
Subsidiaries as of the dates thereof and their consolidated
results of operations and cash flows for the periods then ended
(subject to normal year-end adjustments in the case of any
unaudited interim financial statements).
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='122'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.09." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.09.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Financial
Controls.</I> The management of the Company has
(i)&nbsp;established and maintained disclosure controls and
procedures (as defined in Rule&nbsp;13a-15(e) under the
1934&nbsp;Act) to ensure that information required to be
disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the SEC&#146;s
rules and forms, (ii)&nbsp;established and maintains a system of
internal control over financial reporting (as defined in
Rule&nbsp;13a-15(f) under the 1934&nbsp;Act) designed to provide
reasonable assurance regarding the reliability of the
Company&#146;s financial reporting and the preparation of
Company financial statements for external purposes in accordance
with GAAP and (iii)&nbsp;has disclosed, based on its most recent
evaluation of internal control over financial reporting, to the
Company&#146;s auditors and the audit committee of the
Company&#146;s Board of Directors (A)&nbsp;all significant
deficiencies and material weaknesses in the design or operation
of internal control over financial reporting identified by the
management of the Company which are reasonably likely to
adversely affect the Company&#146;s ability to record, process,
summarize and report financial information and (B)&nbsp;any
fraud, whether or not material, that involves management or
other employees who have a significant role in the
Company&#146;s internal control over financial reporting. The
Company has disclosed to Parent prior to the date hereof all
disclosures described in clause&nbsp;(iii) of the immediately
preceding sentence made prior to the date of this Agreement.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='123'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.10. Disclosure Documents." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Disclosure
Documents.</I> (a)&nbsp;The proxy statement of the Company to be
filed with the SEC in connection with the Merger (the
<B>&#147;Company Proxy Statement&#148;</B>) and any amendments
or supplements thereto will, when filed, comply as to form in
all material respects with the applicable requirements of the
1934&nbsp;Act. At the time the Company Proxy Statement or any
amendment or supplement thereto is first mailed to stockholders
of the Company, and at the time such stockholders vote on
adoption of this Agreement, the Company Proxy Statement, as
supplemented or amended, if applicable, will not contain any
untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made
therein, in the light of the circumstances under which they were
made, not misleading. The representations and warranties
contained in this Section&nbsp;4.10(a) will not apply to
statements or omissions included in the Company Proxy Statement
based upon information furnished to the Company by Parent
specifically for use therein.
</DIV>

<P align="center" style="font-size: 10pt;">18

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;All of the information provided or to be provided by
    the Company specifically for use in the Parent Shareholder
    Circular or in any notification to any regulatory information
    service approved by the UK Listing Authority supplemental to the
    Parent Shareholder Circular, at the time the Parent Shareholder
    Circular is first mailed to shareholders of Parent or at the
    time any such supplemental notification is made, respectively,
    and (in both cases) at the time such shareholders vote on the
    resolutions set forth in the Parent Shareholder Circular, will
    be in accordance with the facts and will not omit anything
    likely to affect the import of such information.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='124'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.11. Absence of Certain Changes." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Absence
of Certain Changes.</I> Since the Balance Sheet Date, the
business of the Company and its Subsidiaries has been conducted
in the ordinary course consistent with past practices and there
has not been:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;any event, occurrence or circumstances that has had, or
    is reasonably be likely to have, individually or in the
    aggregate, a Company Material Adverse Effect;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;any declaration, setting aside or payment of any
    dividend or other distribution with respect to any shares of
    capital stock of the Company, or any repurchase, redemption or
    other acquisition by the Company or any of its Subsidiaries of
    any outstanding shares of capital stock or other securities of,
    or other ownership interests in, the Company or any of its
    Subsidiaries (other than the forfeiture or repurchase of
    restricted Shares granted under a Company Stock Plan);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;any amendment of any material term of any outstanding
    security of the Company or any of its Subsidiaries;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;prior to the date of this Agreement, any incurrence,
    assumption or guarantee by the Company or any of its
    Subsidiaries of any indebtedness for borrowed money other than
    in the ordinary course of business and in amounts and on terms
    consistent with past practices;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;prior to the date of this Agreement, any creation or
    other incurrence by the Company or any of its Subsidiaries of
    any Lien on any material asset other than in the ordinary course
    of business consistent with past practices;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;prior to the date of this Agreement, any making of any
    loan, advance or capital contributions to or investment in any
    Person other than (i)&nbsp;loans, advances or capital
    contributions made in the ordinary course of business consistent
    with past practices or (ii)&nbsp;investments in its wholly-owned
    Subsidiaries made in the ordinary course of business consistent
    with past practices;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;prior to the date of this Agreement, any sale, lease
    (as lessor), license or other disposition of any properties or
    assets that are material, individually or in the aggregate, to
    the Company and its Subsidiaries, taken as a <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">19

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    whole, except sales of assets in the ordinary course of business
    consistent with past practice;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (h)&nbsp;any change in any method of accounting or accounting
    principles or practice by the Company or any of its
    Subsidiaries, except for any such change required by reason of a
    change in GAAP;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (i)&nbsp;prior to the date of this Agreement, any (i)&nbsp;grant
    of any material severance or termination pay to (or material
    amendment to any existing arrangement with) any director or
    officer of the Company or any of its Subsidiaries,
    (ii)&nbsp;increase in the benefits payable under any existing
    severance or termination pay policies or employment or
    consultancy agreements to any director or officer of the Company
    or any of its Subsidiaries, (iii)&nbsp;entering into of any
    employment, consultancy, deferred compensation, severance,
    retirement or other similar agreement (or any amendment to any
    such existing agreement) with any director or officer of the
    Company or any of its Subsidiaries, (iv)&nbsp;establishment,
    adoption or material amendment (except as required to comply
    with applicable law) of any material collective bargaining,
    bonus, profit-sharing, thrift, pension, retirement, deferred
    compensation, compensation, equity compensation or other benefit
    plan or arrangement covering any director or employee of the
    Company or any of its Subsidiaries or (v)&nbsp;increase in
    compensation, bonus or other benefits payable to any director or
    officer of the Company or any of its Subsidiaries, in each case
    other than in the ordinary course of business consistent with
    past practices and other than in connection with the hiring,
    election or promotion of new directors, officers or employees;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (j)&nbsp;any material labor dispute, other than routine
    individual grievances, or to the Knowledge of the Company, any
    material activity or proceeding by a labor union or
    representative thereof to organize any employees of the Company
    or any of its Subsidiaries, which employees were not subject to
    a collective bargaining agreement at the Balance Sheet Date, or
    any lockouts, strikes, slowdowns or work stoppages, or, to the
    Knowledge of the Company threats thereof, by or with respect to
    such employees;&nbsp;or</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (k)&nbsp;any material Tax election made or changed, any annual
    tax accounting period changed, any method of tax accounting
    adopted or changed, any material amended Tax Returns or claims
    for Tax refunds filed, any material closing agreement entered
    into, any Tax claim, audit or assessment settled, or any
    material right to claim a Tax refund, offset or other reduction
    in Tax liability surrendered.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='125'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.12. No Undisclosed Material Liabilities." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;4.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>No
Undisclosed Material Liabilities.</I> There are no liabilities
or obligations of the Company or any of its Subsidiaries of any
kind whatsoever, whether accrued, contingent, absolute,
determined, determinable or otherwise, and there is no existing
condition, situation or set of circumstances that is reasonably
likely to result in such a liability or obligation, other than:
</DIV>

<P align="center" style="font-size: 10pt;">20

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;liabilities or obligations disclosed and provided for
    in the Balance Sheet or in the notes thereto or in the Company
    10-K or any Company SEC Document filed subsequent to the filing
    of the Company 10-K but prior to the date hereof (the
    <B>&#147;Current SEC Documents&#148;</B>);&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;liabilities or obligations incurred in the ordinary
    course of business consistent with past practices since the
    Balance Sheet Date that are not reasonably likely to have,
    individually or in the aggregate, a Company Material Adverse
    Effect.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='126'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.13. Compliance with Laws and Court Orders." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance
with Laws and Court Orders.</I> The Company and each of its
Subsidiaries is, and since January&nbsp;1, 2002 has been, in
compliance with, and to the Knowledge of the Company is not
under investigation with respect to and has not been threatened
to be charged with or been given notice of any violation of, any
applicable law, statute, ordinance, rule, regulation, judgment,
injunction, order or decree, except for failures to comply or
violations that are not reasonably likely to have, individually
or in the aggregate, a Company Material Adverse Effect.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='127'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.14. Litigation." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Litigation.</I>
There is no action, suit, investigation or proceeding
(a)&nbsp;pending against, or, to the Knowledge of the Company,
threatened against the Company or any of its Subsidiaries or
their respective properties or any Company Employees Plan or
Company International Plan or (b)&nbsp;to the Knowledge of the
Company, pending or threatened against any present or former
officer, director or employee of the Company or any of its
Subsidiaries in respect of which action the Company or any of
its Subsidiaries has indemnification obligations arising under
applicable charter provisions, bylaw provisions or
indemnification agreements, in each case, before any court or
arbitrator or before or by any governmental body, agency or
official, domestic, foreign or supranational, that is reasonably
likely to have, individually or in the aggregate, a Company
Material Adverse Effect.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='128'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.15. Finders&#146; Fees." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Finders&#146;
Fees.</I> Except for SG Cowen&nbsp;&#38; Co., LLC and Banc of
America Securities LLC, copies of whose engagement agreements
have been provided to Parent, there is no investment banker,
broker, finder or other financial intermediary that has been
retained by or is authorized to act on behalf of the Company or
any of its Subsidiaries who would be entitled to any fee or
commission in connection with the transactions contemplated by
the Transaction Agreements.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='129'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.16. Taxes." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Taxes.</I>
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;All material Tax Returns required by applicable law to
    be filed with any Taxing Authority by, or on behalf of, the
    Company or any of its Subsidiaries have been filed when due
    (including any permitted extensions of time) in accordance with
    all applicable laws, and all such Tax Returns are, or will be at
    the time of filing, true and complete in all material respects,
    except for any errors or <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">21

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    omissions that are not reasonably likely to have, individually
    or in the aggregate, a Company Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;All Taxes shown as due on the Tax Returns filed by, or
    on behalf of, the Company or any of its Subsidiaries have been
    timely paid. The most recent financial statements contained in
    the Company SEC Documents reflect an adequate reserve for all
    Taxes payable by the Company and its Subsidiaries for all
    Taxable periods and portions thereof through the date of such
    financial statements.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;The income and franchise Tax Returns of the Company and
    its Subsidiaries through the Tax year ended 1999 have been
    examined and closed or are Tax Returns with respect to which the
    applicable period for assessment under applicable law, after
    giving effect to extensions or waivers, has expired.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;There is no claim, audit, action, suit, proceeding or
    investigation now pending or threatened in writing against or
    with respect to the Company or its Subsidiaries in respect of
    any Tax, except for any claims, audits, actions, suits,
    proceedings or investigations that are not reasonably likely to
    have, individually or in the aggregate, a Company Material
    Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;During the five-year period ending on the date hereof,
    neither the Company nor any of its Subsidiaries was a
    distributing corporation or a controlled corporation in a
    transaction intended to be governed by Section&nbsp;355 of the
    Code.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;There are no Liens for Taxes (other than for current
    Taxes not yet due and payable) on the assets of the Company or
    any of its Subsidiaries, except for any Liens that are not
    reasonably likely to have, individually or in the aggregate, a
    Company Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;<B>&#147;Tax&#148;</B> means (i)&nbsp;any tax,
    governmental fee or other like assessment or charge in the
    nature of a tax (including, but not limited to, withholding on
    amounts paid to or by any Person), together with any interest,
    penalty, addition to tax or additional amount imposed by any
    governmental authority (a <B>&#147;Taxing Authority&#148;</B>)
    responsible for the imposition of any such tax (domestic or
    foreign), and any liability for any of the foregoing as
    transferee, (ii)&nbsp;in the case of the Company or any of its
    Subsidiaries, any liability for the payment of any amount of the
    type described in clause&nbsp;(i) as a result of being or having
    been before the Effective Time a member of an affiliated,
    consolidated, combined or unitary group, or a party to any
    agreement or arrangement, as a result of which liability of the
    Company or any of its Subsidiaries to a Taxing Authority is
    determined or taken into account with reference to the
    activities of any other Person, and (iii)&nbsp;any liability of
    the Company or any of its Subsidiaries for the payment of any
    amount as a result of being party to any tax sharing agreement
    or with respect to the payment of any amount imposed on any
    person of the type described in (i)&nbsp;or (ii)&nbsp;as a
    result of any existing express or implied agreement or
    arrangement (including an indemnification agreement or
    arrangement). <B>&#147;Tax Return&#148;</B> means <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">22

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    any report, return, document, declaration or other information
    or filing required to be supplied to any Taxing Authority with
    respect to Taxes, including information returns, any documents
    with respect to or accompanying payments of estimated Taxes, or
    with respect to or accompanying requests for the extension of
    time in which to file any such report, return, document,
    declaration or other information.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='130'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.17. Personnel Matters." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Personnel
Matters.</I> (a)&nbsp;Section&nbsp;4.17(a) of the Company
Disclosure Schedule contains a correct and complete list
identifying each material Company Employee Plan. Copies of each
material Company Employee Plan and any material amendments
thereto have been furnished to Parent, and copies of, to the
extent applicable, any related trust or funding agreements or
insurance policies, amendments thereto, prospectuses or summary
plan descriptions relating thereto and the most recent annual
report (Form&nbsp;5500 including, if applicable, Schedule&nbsp;B
thereto) and tax return (Form&nbsp;990) prepared in connection
therewith have been furnished to Parent.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;Neither the Company nor any of its Subsidiaries nor any
    of their respective ERISA Affiliates nor any predecessor thereof
    sponsors, maintains or contributes to, or has in the past
    sponsored, maintained or contributed to, any Employee Plan
    subject to Title&nbsp;IV of ERISA.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;Neither the Company nor of its Subsidiaries nor any of
    their respective any ERISA Affiliate nor any predecessor thereof
    contributes to, or has in the past contributed to, any
    &#147;multiemployer plan&#148;, as defined in Section&nbsp;3(37)
    of ERISA.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;Each Company Employee Plan that is intended to be
    qualified under Section&nbsp;401(a) of the Code has received a
    favorable determination letter, or has pending or has time
    remaining in which to file an application for such determination
    from the Internal Revenue Service, and the Company is not aware
    of any reason why any such determination letter should be
    revoked or not be issued. The Company has furnished to Parent
    copies of the most recent Internal Revenue Service determination
    letters with respect to each such Company Employee Plan. Each
    Company Employee Plan has been maintained in material compliance
    with its terms and with the requirements prescribed by any and
    all statutes, orders, rules and regulations, including ERISA and
    the Code, which are applicable to such Company Employee Plan. No
    events have occurred with respect to any Company Employee Plan
    that could result in payment or assessment by or against the
    Company or any of its Subsidiaries or any of their respective
    ERISA Affiliates of any material excise taxes under
    Sections&nbsp;4972, 4975, 4976, 4977, 4979, 4980B, 4980D, 4980E
    or 5000 of the Code.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;Neither the Company nor any of its Subsidiaries has any
    liability in respect of post-retirement health, medical or life
    insurance benefits for retired, former or current employees of
    the Company or any of its Subsidiaries, except as required to
    comply with applicable law.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">23

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;Section&nbsp;4.17(f) of the Company Disclosure Schedule
    contains a correct and complete list identifying each material
    Company International Plan. Copies of each material Company
    International Plan and any material amendments thereto have been
    furnished to Parent, and copies of, to the extent applicable,
    any related trust or funding agreements or insurance policies,
    amendments thereto and regulatory filings or similar documents
    that have been prepared therewith have been furnished to Parent.
    Each Company International Plan has been maintained in material
    compliance with its terms and with the requirements prescribed
    by any and all applicable laws (including any special provisions
    relating to qualified plans where such Company International
    Plan was intended so to qualify) and has been maintained in good
    standing with applicable regulatory authorities.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;Except as set forth in Section&nbsp;4.17(g) of the
    Company Disclosure Schedule, no Company Employee Plan or Company
    International Plan provides for, as a result of the transactions
    contemplated by this Agreement (whether alone or in connection
    with other events), any payment of any material amount of money
    or other property to or the acceleration of or provision of any
    other material rights or benefits to any present or former
    employee or director of the Company or any of its Subsidiaries,
    whether or not such payment, right or benefit would constitute a
    parachute payment within the meaning of Section&nbsp;280G of the
    Code.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (h)&nbsp;Neither the Company nor any of its Subsidiaries is a
    party to or otherwise bound by any collective bargaining
    agreement, contract or other agreement or understanding with a
    labor union or labor organization. No labor strike, slowdown or
    stoppage is actually pending or, to the Knowledge of the
    Company, threatened against or affecting the Company or any of
    its Subsidiaries.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (i)&nbsp;Since the Balance Sheet Date, neither the Company nor
    any of its Subsidiaries has effectuated (i)&nbsp;a &#147;plant
    closing&#148; (as defined in the Worker Adjustment and
    Retraining Notification Act (the <B>&#147;WARN Act&#148;</B>))
    affecting any site of employment or one or more facilities or
    operating units within any site of employment or facility of the
    Company or any of its Subsidiaries; (ii)&nbsp;a &#147;mass
    layoff&#148; (as defined in the WARN Act); or (iii)&nbsp;such
    other transaction, layoff, reduction in force or employment
    terminations sufficient in number to trigger application of any
    similar foreign, state or local law.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='131'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.18. Environmental Matters." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Environmental
Matters.</I> (a)&nbsp;With such exceptions as are not reasonably
likely to have, individually or in the aggregate, a Company
Material Adverse Effect:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (i)&nbsp;no notice, notification, demand, request for
    information, citation, summons or order has been received by the
    Company or any of its Subsidiaries, no complaint has been filed,
    no penalty has been assessed against the Company, and, to the
    Knowledge of the Company, no investigation, action, claim, suit,
    proceeding or review is pending or is <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">24

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    threatened against the Company or any of its Subsidiaries by any
    governmental authority relating to or arising out of any
    Environmental Law;&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (ii)&nbsp;the Company and its Subsidiaries are and have been in
    compliance with all Environmental Laws and all Environmental
    Permits.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;There has been no environmental investigation, study,
    audit, test, review or other analysis conducted of which the
    Company has Knowledge in relation to the current or prior
    business of the Company or any of its Subsidiaries or any
    property or facility now or previously owned or leased by the
    Company or any of its Subsidiaries that has not been delivered
    to Parent prior to the date hereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;Neither the Company nor any of its Subsidiaries owns,
    leases or operates or has owned, leased or operated any real
    property, or conducts or has conducted any operations, in New
    Jersey or Connecticut.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;For purposes of this Section&nbsp;4.18, the terms
    &#147;Company&#148; and &#147;Subsidiaries&#148; shall include
    any entity that is, in whole or in part, a predecessor of the
    Company or any of its Subsidiaries.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='132'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.19. Intellectual Property." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Intellectual
Property.</I> (a)&nbsp;Section&nbsp;4.19(a)-1 of the Company
Disclosure Schedule contains a true and complete list of each of
the registrations and applications for registration of
Intellectual Property Rights included in the Owned Intellectual
Property Rights that are material to the Company and its
Subsidiaries, taken as whole. Section&nbsp;4.19(a)-2 of the
Company Disclosure Schedule contains a true and complete list of
all agreements (including license agreements, research
agreements, development agreements, distribution agreements,
settlement agreements, consent to use agreements and covenants
not to sue, but excluding licenses for personal computer
software that are generally available on nondiscriminatory
pricing terms and have an acquisition cost of $100,000 or less)
to which the Company or any of its Subsidiaries is a party or
otherwise bound, granting or restricting any right to use,
exploit or practice any Intellectual Property Rights that are
used or held for use by the Company or any of its Subsidiaries
and that are material to the Company and its Subsidiaries, taken
as whole (each, a <B>&#147;License Agreement&#148;</B>).
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;To the Knowledge of the Company, the Licensed
    Intellectual Property Rights and the Owned Intellectual Property
    Rights together constitute all the Intellectual Property Rights
    necessary to, or used or held for use in, the business of the
    Company and its Subsidiaries as currently conducted. The
    consummation of the transactions contemplated by this Agreement
    will not alter, encumber, impair or extinguish in any material
    respect any Owned Intellectual Property Rights or Licensed
    Intellectual Property Rights that are material to the Company
    and its Subsidiaries, taken as a whole.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">25

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;Neither the Company nor any Subsidiary of the Company
    has given to any Person an indemnity in connection with any
    Intellectual Property Right, other than indemnities that,
    individually or in the aggregate, are not reasonably likely to
    result in a material liability to the Company or any of its
    Subsidiaries.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;Except as would not be reasonably likely to have a
    Company Material Adverse Effect, neither the Company nor any
    Subsidiary of the Company has infringed, misappropriated or
    otherwise violated any Intellectual Property Right of any third
    party. The Company and the Subsidiaries of the Company are in
    compliance with, and are not in breach of any term of any of the
    License Agreements and, to the Knowledge of the Company, all
    other parties to such License Agreements are in compliance with,
    and have not breached any term of, such License Agreements,
    except for any failure to comply or breach that is not
    reasonably likely to have, individually or in the aggregate, a
    Company Material Adverse Effect. There is no claim, action,
    suit, investigation or proceeding pending against, or, to the
    Knowledge of the Company, threatened in writing against, the
    Company or any of its Subsidiaries (i)&nbsp;based upon, or
    challenging or seeking to deny or restrict, the rights of the
    Company or any Subsidiary of the Company in any of the Owned
    Intellectual Property Rights and the Licensed Intellectual
    Property Rights that are material to the Company and its
    Subsidiaries, taken as a whole, or (ii)&nbsp;alleging that the
    use of the Owned Intellectual Property Rights or the Licensed
    Intellectual Property Rights or any services provided, processes
    used or products manufactured, used, imported or sold by the
    Company or any of its Subsidiaries conflict with,
    misappropriate, infringe or otherwise violate any Intellectual
    Property Right of any third party.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;None of the registered Owned Intellectual Property
    Rights and registered Licensed Intellectual Property Rights
    material to the Company and its Subsidiaries, taken as a whole,
    has been adjudged by a court or administrative body of competent
    jurisdiction invalid or unenforceable in whole or part, and, to
    the Knowledge of the Company, all such registered Owned
    Intellectual Property Rights and registered Licensed
    Intellectual Property Rights are valid and enforceable.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;The Company or a Subsidiary of the Company holds all
    right, title and interest in and to all Owned Intellectual
    Property Rights that are material to the Company and its
    Subsidiaries, taken as a whole, and all right, title and
    interest in licenses to all Licensed Intellectual Property
    Rights that are material to the Company and its Subsidiaries,
    taken as a whole, in each case, free and clear of any Lien. In
    each case where a patent or patent application, trademark
    registration or trademark application, service mark registration
    or service mark application, or copyright registration or
    copyright application included in the Owned Intellectual
    Property is held by assignment, the assignment has been duly
    recorded with the governmental authority from which the patent
    or registration issued or before which the application or
    application for registration is pending, except any failure to
    duly record that is not reasonably likely to have, individually
    or in the aggregate, a Company Material Adverse Effect. The
    Company or a <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">26

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Subsidiary of the Company has taken commercially reasonable
    actions to maintain and protect the registered Owned
    Intellectual Property Rights and the registered Licensed
    Intellectual Property Rights (to the extent the Company has the
    right to take such actions with respect to such Licensed
    Intellectual Property) that are material to the Company and its
    Subsidiaries, taken as a whole, including payment of applicable
    maintenance fees and filing of applicable statements of use.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;To the Knowledge of the Company, no Person has
    infringed, misappropriated or otherwise violated any Owned
    Intellectual Property Rights or Licensed Intellectual Property
    Rights that are material to the Company and its Subsidiaries,
    taken as a whole, in a manner that would be reasonably likely to
    have a Company Material Adverse Effect. The Company or a
    Subsidiary of the Company has taken reasonable steps in
    accordance with normal industry practice to maintain the
    confidentiality of all confidential Intellectual Property
    Rights, except any failure to take such steps that is not
    reasonably likely to have, individually or in the aggregate, a
    Company Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (h)&nbsp;To the Knowledge of the Company, none of the
    trademarks, service marks, applications for trademarks and
    applications for service marks included in the Owned
    Intellectual Property Rights that are material to the Company
    and its Subsidiaries, taken as a whole, are subject to a pending
    opposition or cancellation procedure. To the Knowledge of the
    Company, none of the patents and patent applications included in
    the Owned Intellectual Property Rights or the Licensed
    Intellectual Property Rights that are material to the Company
    and its Subsidiaries, taken as a whole, is the subject of an
    interference, protest, public use proceeding, opposition,
    revocation proceeding, third party reexamination request or
    compulsory licensing arrangement.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (i)&nbsp;To the Knowledge of the Company, the Company or a
    Subsidiary of the Company owns or has the right to use all
    Intellectual Property Rights necessary to use the HT 1080 cell
    line obtained from the American Type Culture Collection in the
    manufacture of the products sold by the Company or a Subsidiary
    of the Company.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='133'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.20. Regulatory Matters." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Regulatory
Matters.</I> (a)&nbsp;With only such exceptions as are not
reasonably likely to have, individually or in the aggregate, a
Company Material Adverse Effect, all manufacturing, processing,
distribution, labeling, storage, testing, specifications, sale
or marketing of products performed by or on behalf of the
Company or any of its Subsidiaries are in compliance with all
applicable laws, rules, regulations, or orders administered or
issued by any governmental or supranational regulatory
authority, including the Food and Drug Administration
<B>(&#147;FDA&#148;</B>), the Drug Enforcement Agency, or any
counterpart regulatory authorities in the European Union.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;With only such exceptions as are not reasonably likely
    to have, individually or in the aggregate, a Company Material
    Adverse Effect, all pre-clinical and clinical investigations
    conducted or sponsored by the Company or <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">27

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    any of its Subsidiaries are being conducted in compliance with
    all applicable laws, rules, and regulations, administered or
    issued by the FDA or any counterpart regulatory authorities in
    the European Union, including: the FDA&#146;s standards for
    conducting non clinical laboratory studies contained in
    Title&nbsp;21 part 58 of the Code of Federal Regulations;
    investigational new drug requirements; the FDA&#146;s standards
    for the design, conduct, performance, monitoring, auditing,
    recording, analysis and reporting of clinical trials contained
    in Title&nbsp;21 parts 50, 54, 56, 312, 314, and 320 of the Code
    of Federal Regulations (including informed consent and
    institutional review boards designed to ensure the protection of
    rights and welfare of human subjects); federal and state laws,
    rules and regulations restricting the use and disclosure of
    individually identifiable health information; and, as
    applicable, the International Conference on Harmonisation
    (ICH)&nbsp;GCP consolidated Guideline (E6). Neither the Company
    nor any of its Subsidiaries has received any written information
    from the FDA, or, to the extent applicable, counterpart
    regulators in the European Union, which would reasonably be
    expected to lead to the denial of any application for marketing
    approval currently pending before the FDA, or, to the extent
    applicable, counterpart regulators in the European Union.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;Neither the Company nor any of its Subsidiaries has
    received any oral or written communication (including any
    warning letter, untitled letter, Form&nbsp;483s or similar
    notices) from the FDA or any counterpart regulatory authorities
    in the European Union, and to the Company&#146;s Knowledge there
    is no action or proceeding pending or threatened (including any
    prosecution, injunction, seizure, civil fine, suspension or
    recall), in each case alleging that the Company or any of its
    Subsidiaries is not currently in compliance with any and all
    applicable laws, regulations or orders implemented by the FDA,
    the Drug Enforcement Agency, any counterpart regulatory
    authorities in the European Union or any other country, with
    only such exceptions as are not reasonably likely to have,
    individually or in the aggregate, a Company Material Adverse
    Effect. There are no pending voluntary or involuntary market
    withdrawals, field corrective actions (including recalls),
    destruction orders, seizures or other regulatory enforcement
    actions related to any product that are reasonably likely to
    have, individually or in the aggregate, a Company Material
    Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;Neither the Company nor any of its Subsidiaries has
    received any correspondence from the FDA, or a counterpart
    regulatory authority in the European Union, regarding, and, to
    the Company&#146;s Knowledge, there is no pending or threatened
    action or proceeding against, the Company or any of its
    Subsidiaries or any of its employees regarding any debarment
    action or investigation undertaken pursuant to the Generic Drug
    Enforcement Act of 1992 (21&nbsp;U.S.C. Sections&nbsp;335(a),
    (b)&nbsp;and (c)), or any similar regulation of the FDA or any
    similar regulation of any counterpart regulatory authority in
    the European Union, except for any action or proceeding that is
    not reasonably likely to have, individually or in the aggregate,
    a Company Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;To the Company&#146;s Knowledge, no data generated by
    the Company or any of its Subsidiaries with respect to its
    products that has been provided to its <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">28

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    customers or otherwise made public is the subject of any
    regulatory or other action, either pending or threatened, by the
    FDA or any other comparable governmental authority relating to
    the truthfulness or scientific adequacy of such data.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;Neither the Company nor any of its Subsidiaries is
    subject to any pending or, to the Knowledge of the Company,
    threatened, investigation by (i)&nbsp;the FDA pursuant to its
    Fraud, Untrue, Material Facts, Bribery, and Illegal Gratuities
    Final Policy, (ii)&nbsp;the Department of Health and Human
    Services Office of Inspector General or Department of Justice
    pursuant to the Federal Anti-Kickback Statute (42&nbsp;U.S.C.
    Section&nbsp;1320a-7(b)) or the Civil False Claims Act
    (31&nbsp;U.S.C. Section&nbsp;3729 <I>et seq.</I>) or
    (iii)&nbsp;any equivalent statute or policy of or in any country
    in the European Union, and to the Knowledge of the Company,
    there is no basis therefor.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;The Company has, prior to the execution of this
    Agreement, made available to Parent copies of any and all
    documents in its or any of its Subsidiaries&#146; possession
    that are material to assessing the Company&#146;s or any of its
    Subsidiaries&#146; compliance with the Federal Food, Drug and
    Cosmetic Act or the International Standards Organization and
    their respective implementing regulations or any other similar
    regulations in any applicable jurisdiction.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='134'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.21. Material Contracts." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;4.21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Material
Contracts.</I> (a)&nbsp;All of the material contracts (the
<B>&#147;Material Contracts&#148;</B>) of the Company and its
Subsidiaries that are required to be described in the Company
SEC Documents (or to be filed as exhibits thereto) are so
described in the Company SEC Documents (or filed as exhibits
thereto) and are in full force and effect. Neither the Company
nor any of its Subsidiaries is a party to or bound by any
contract (a <B>&#147;Product Contract&#148;</B>) that relates to
the research, development, distribution, supply, license,
co-promotion or manufacturing of any Key Product which, if
terminated or not renewed, is reasonably likely to have a
material adverse effect on any Key Product. Each Product
Contract set forth in Section&nbsp;4.21(a) of the Company
Disclosure Schedule is in full force and effect. True and
complete copies of all Material Contracts and Product Contracts
have been made available by the Company to Parent. Neither the
Company nor any of its Subsidiaries nor, to the Knowledge of the
Company, any other party is in breach of or in default under any
Material Contract or Product Contract, except for such breaches
and defaults as are not reasonably likely to have, individually
or in the aggregate, a Company Material Adverse Effect.
<B>&#147;Key Product&#148;</B> means any of Replagal,
Iduronate-2-Sulfatase for Hunter syndrome and Gene-Activated
Glucocerebrosidase for Gaucher disease.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;Neither the Company nor any of its Subsidiaries is
    party to any agreement containing any provision or covenant
    limiting in any material respect the ability of the Company or
    any of its Subsidiaries (or, after the consummation of the
    Merger, Parent, the Surviving Corporation or any of their
    respective Subsidiaries) to (i)&nbsp;sell any products or
    services of or to any other Person, (ii)&nbsp;engage in any line
    of business or (iii)&nbsp;compete with or to obtain products or
    <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">29

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    services from any Person or limiting the ability of any Person
    to provide products or services to Parent or any of its
    Subsidiaries (or, after the consummation of the Merger, Parent,
    the Surviving Corporation or any of their respective
    Subsidiaries), in each case under this Section&nbsp;4.21(b)
    other than any territorial restriction contained in a license or
    distribution agreement disclosed to Parent pursuant to
    Section&nbsp;4.19 or entered into after the date of this
    Agreement in the ordinary course of business in compliance with
    the terms of this Agreement, which restriction is applicable
    solely to the product licensed or distributed under such
    agreement.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='135'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.22. Opinion of Financial Advisors." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
of Financial Advisors.</I> The Company has received the opinions
of SG Cowen&nbsp;&#38; Co., LLC and Banc of America Securities
LLC, financial advisors to the Company, to the effect that, as
of the date of this Agreement, the Merger Consideration is fair
to the Company&#146;s stockholders from a financial point of
view.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='136'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.23. Antitakeover Statutes and Rights Agreement." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;4.23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Antitakeover
Statutes and Rights Agreement.</I> (a)&nbsp;Assuming that the
representation in Section&nbsp;5.08 is true and correct, the
Company has taken all action necessary to exempt the Merger,
this Agreement, the Voting Agreement and the transactions
contemplated hereby and thereby from Section&nbsp;203 of the
Delaware Law, and, accordingly, such Section does not apply to
any such transactions. No other &#147;control share
acquisition,&#148; &#147;fair price,&#148;
&#147;moratorium&#148; or other antitakeover laws or regulations
enacted under U.S.&nbsp;state or federal laws apply to this
Agreement or any of the transactions contemplated hereby.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;The Company has taken all action necessary to render
    the rights issued pursuant to the terms of the Company&#146;s
    Rights Agreement dated December&nbsp;31, 2000 between the
    Company and Equiserve Trust Company, N.A., inapplicable to the
    Merger, this Agreement, the Voting Agreement and the
    transactions contemplated hereby and thereby.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='137'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.24. Hunter Data." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;4.24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Hunter
Data.</I> As of the date of this Agreement, the Company has
furnished all material information, results and analyses of
which it has Knowledge relating to the effect of the
Company&#146;s Iduronate-2-Sulfatase product
<B>(&#147;I2S&#148;</B>) on patients with Hunter syndrome (the
<B>&#147;Hunter Data&#148;</B>) to Parent. As of the date of
this Agreement, the Company has no Knowledge as to the likely
results of the AIM Study.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='138'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 4.25. Dynepo License." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;4.25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Dynepo
License.</I> The license agreement provided to Parent prior to
the date of this Agreement (and attached as Section&nbsp;4.25 of
the Company Disclosure Schedules) is the license agreement (with
names and commercial payment terms redacted) negotiated by the
Company at arms&#146;-length with a <U>bona</U> <U>fide</U>
Third Party with respect to the manufacture, distribution and
sale of Dynepo outside of North America.
</DIV>

<P align="center" style="font-size: 10pt;">30

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;5
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Representations and
Warranties of Parent
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Parent represents and warrants to the Company that:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='139'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.01. Corporate Existence and Power." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;5.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Corporate
Existence and Power.</I> Each of Parent and Merger Subsidiary is
duly incorporated, duly organized, validly existing and, in the
case of Merger Subsidiary only, in good standing under the laws
of its jurisdiction of incorporation and has all corporate
powers and all governmental licenses, authorizations, permits,
consents and approvals required to carry on its business as now
conducted, except for those licenses, authorizations, permits,
consents and approvals the absence of which are not reasonably
likely to have, individually or in the aggregate, a Parent
Material Adverse Effect. Parent has heretofore made available to
the Company true and complete copies of the organizational
documents of Parent and the certificate of incorporation and
bylaws of Merger Subsidiary as currently in effect. Since the
date of its incorporation, Merger Subsidiary has not engaged in
any activities other than in connection with or as contemplated
by this Agreement.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='140'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.02. Corporate Authorization." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;5.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Corporate
Authorization.</I> The execution, delivery and performance by
Parent and Merger Subsidiary of each Transaction Agreement to
which it is a party and the consummation by Parent and Merger
Subsidiary of the transactions contemplated thereby are within
the corporate powers of Parent and Merger Subsidiary and, except
for the required approval of Parent&#146;s shareholders and the
adoption of this Agreement by the sole stockholder of Merger
Subsidiary, which in the case of Merger Subsidiary will be
obtained promptly after the execution and delivery of this
Agreement, in connection with the consummation of the
transactions contemplated thereby, have been duly authorized by
all necessary company action on the part of Parent and Merger
Subsidiary. The only vote of the holders of any of Parent&#146;s
share capital necessary in connection with the consummation of
the transactions contemplated by the Transaction Agreements is
the affirmative vote on a show of hands of a simple majority of
the holders of ordinary shares of Parent present in person at a
duly convened general meeting of Parent, or the affirmative vote
on a poll of a simple majority of the votes attached to the
issued ordinary shares of Parent voted in person or by proxy at
such a general meeting in favor of the Merger. For the avoidance
of doubt, no vote of the holders of any of Parent&#146;s share
capital is necessary in connection with the entry into and
performance by Parent of the Dynepo License Agreement. Each
Transaction Agreement to which it is a party constitutes a valid
and binding agreement of each of Parent and Merger Subsidiary,
enforceable against each of Parent and Merger Subsidiary in
accordance with its terms, except (i)&nbsp;as the same may be
limited by applicable bankruptcy, insolvency, reorganization,
fraudulent conveyance, moratorium or similar laws of general
application relating to or affecting creditors&#146; rights and
(ii)&nbsp;for the limitations imposed by general principles of
equity (regardless of whether considered in a proceeding at law
or in equity).
</DIV>

<P align="center" style="font-size: 10pt;">31

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='141'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.03. Governmental Authorization." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;5.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governmental
Authorization.</I> The execution, delivery and performance by
Parent and Merger Subsidiary of each Transaction Agreement to
which it is a party and the consummation by Parent and Merger
Subsidiary of the transactions contemplated thereby require no
action by Parent or Merger Subsidiary by or in respect of, or
filing by Parent or Merger Subsidiary with, any governmental
body, agency, official or authority, domestic, foreign or
supranational, other than (i)&nbsp;the filing of a certificate
of merger with respect to the Merger with the Delaware Secretary
of State, (ii)&nbsp;compliance with any applicable requirements
of the HSR Act and any applicable competition, antitrust or
similar law of any jurisdiction outside the United States,
(iii)&nbsp;compliance with any applicable requirements of the
1934&nbsp;Act and the rules and regulations promulgated
thereunder, (iv)&nbsp;such consents, approvals, orders,
authorizations, registrations, declarations and filings as may
be required under applicable state securities laws and the
securities laws of any foreign country (including any approvals
contemplated by Section&nbsp;7.01) and (v)&nbsp;any actions or
filings the failure of which to take is not reasonably likely to
have, individually or in the aggregate, a Parent Material
Adverse Effect. To the Knowledge of Parent, as of the date of
this Agreement, there is no material issue with regard to the
transactions contemplated by the Transaction Agreements under
the HSR Act or any applicable competition, antitrust or similar
law of any jurisdiction outside the United States.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='142'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.04. Non-contravention." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;5.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Non-contravention.</I>
The execution, delivery and performance by Parent and Merger
Subsidiary of each Transaction Agreement to which it is a party
and the consummation by Parent and Merger Subsidiary of the
transactions contemplated thereby do not and will not
(i)&nbsp;contravene, conflict with or result in any violation or
breach of any provision of the organizational documents of
Parent or the certificate of incorporation or bylaws of Merger
Subsidiary, (ii)&nbsp;assuming compliance with the matters
referred to in Section&nbsp;5.03, contravene, conflict with or
result in any violation or breach of any provision of any law,
rule, regulation, judgment, injunction, order or decree
applicable to Parent or Merger Subsidiary, (iii)&nbsp;require
any consent or other action by any Person under, constitute a
default or an event that, with or without notice or lapse of
time or both, would constitute a default, under, or cause or
permit the termination, cancellation, acceleration or the loss
of any material benefit to which Parent or any of its
Subsidiaries is entitled under any provision of any agreement,
other instrument, license, franchise, permit, certificate,
approval or other similar authorization to which Parent or any
of its Subsidiaries is a party or by which any of their
respective assets are bound or (iv)&nbsp;result in the creation
or imposition of any Lien on any asset of Parent or any of its
Subsidiaries, except in the case of clauses&nbsp;(ii), (iii) and
(iv) for such contraventions, conflicts, violations or breaches,
failures to obtain any such consent or take any other action,
defaults, terminations, cancellations, accelerations, losses or
Liens that are not reasonably likely to have, individually or in
the aggregate, a Parent Material Adverse Effect.
</DIV>

<P align="center" style="font-size: 10pt;">32

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='143'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.05. Disclosure Documents." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;5.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Disclosure
Documents.</I> (a)&nbsp;The shareholder circular to be prepared
by Parent and delivered to its shareholders in connection with
the Merger (the <B>&#147;Parent Shareholder Circular&#148;</B>)
will, at the time it is first mailed to shareholders of Parent,
be in accordance with facts and will not omit anything likely to
affect the import of the information contained in such Parent
Shareholder Circular. As of the time of the shareholder vote
with respect to the approval of the Merger, Parent shall have
duly provided its shareholders, to the extent that Parent is
obligated to do so, with all notices as to changes in relevant
facts or circumstances since the delivery of the Parent
Shareholder Circular that are necessary in order for such
shareholders to duly vote upon the resolutions relating to the
Merger at such time. The representations and warranties
contained in this Section&nbsp;5.05(a) will not apply to
statements or omissions included in the Parent Shareholder
Circular or any supplemental notification based upon information
furnished to Parent by the Company specifically for use therein.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;None of the information provided or to be provided by
    Parent specifically for use in the Company Proxy Statement or
    any amendment or supplement thereto, at the time the Company
    Proxy Statement or any amendment or supplement thereto is first
    mailed to stockholders of the Company and at the time the
    stockholders vote on adoption of this Agreement, will contain
    any untrue statement of a material fact or omit to state any
    material fact necessary in order to make the statements made
    therein, in the light of the circumstances under which they were
    made, not misleading.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='144'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.06. Finders&#146; Fees." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;5.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Finders&#146;
Fees.</I> Except for Goldman Sachs International and
Parent&#146;s other financial advisors, whose fees, in each
case, will be paid by Parent, there is no investment banker,
broker, finder or other financial intermediary that has been
retained by or is authorized to act on behalf of Parent who is
entitled to any fee or commission in connection with the
transactions contemplated by the Transaction Agreements.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='145'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.07. Financing." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;5.07.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Financing.</I>
Parent will have at the Effective Time sufficient funds
available to enable it to pay the Merger Consideration and
consummate the transactions contemplated hereby.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='146'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 5.08. Interested Stockholder." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;5.08.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Interested
Stockholder.</I> None of Parent, Merger Subsidiary or any of
their &#147;affiliates&#148; or &#147;associates&#148; is, or
has been within the last three years, an &#147;interested
stockholder&#148; of the Company as those terms are defined in
Section&nbsp;203 of the Delaware Law.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;6
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Covenants of the Company
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Company agrees that:
</DIV>

<P align="center" style="font-size: 10pt;">33

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='147'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 6.01. Conduct of the Company." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;6.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Conduct
of the Company.</I> Except as set forth in Section&nbsp;6.01 of
the Company Disclosure Schedule or as otherwise specifically
contemplated by this Agreement, from the date of this Agreement
until the Effective Time, the Company and its Subsidiaries shall
conduct their business in all material respects in the ordinary
course consistent with past practice and shall use their
reasonable best efforts to preserve intact their business
organizations and relationships with third parties and to keep
available the services of their present officers and employees.
Without limiting the generality of the foregoing, from the date
hereof until the Effective Time, except as set forth in
Section&nbsp;6.01 of the Company Disclosure Schedule or as
specifically contemplated by this Agreement or with the prior
written consent of Parent:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;the Company shall not adopt or propose any change to
    its certificate of incorporation or bylaws;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, merge or consolidate with any other Person or
    acquire a material amount of stock or assets of any other Person;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, sell, lease, license or otherwise dispose of
    any material Subsidiary or material amount of assets, securities
    or property (other than (i)&nbsp;pursuant to existing contracts
    or commitments, (ii)&nbsp;sales of inventory in the ordinary
    course of business consistent with past practices and
    (iii)&nbsp;dispositions to wholly-owned domestic Subsidiaries of
    the Company);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;the Company shall not declare, set aside or pay any
    dividend or other distribution with respect to any shares of
    capital stock of the Company, or repurchase, redeem or otherwise
    acquire any outstanding shares of capital stock or other
    securities of, or other ownership interests in, the Company or
    any of its Subsidiaries (other than the forfeiture or repurchase
    of restricted Shares granted under a Company Stock Plan);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, amend any material term of any outstanding
    security of the Company or any of its Subsidiaries;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, create or incur any Lien on any material asset
    (other than any immaterial Lien incurred in the ordinary course
    of business);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, incur, assume or guarantee of any indebtedness
    for borrowed money (other than indebtedness owed to the Company
    or one of its wholly-owned Subsidiaries);</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">34

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (h)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, make any loan, advance or capital contributions
    to or investment in any Person (other than (i)&nbsp;investments
    in its wholly-owned Subsidiaries made in the ordinary course of
    business consistent with past practices and (ii)&nbsp;advances
    to employees for business travel expenses consistent with past
    practices and in no event in excess of $10,000&nbsp;per advance);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (i)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, make any change in any method of accounting or
    accounting principles or practice, except for any such change
    required by reason of a change in GAAP;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (j)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, enter into or amend in any material respect any
    material contract, agreement or arrangement (other than
    (i)&nbsp;contracts entered into in the ordinary course of
    business consistent with past practices providing for payments
    not in excess of $100,000&nbsp;per contract and
    (ii)&nbsp;clinical, supply and manufacturing contracts entered
    into in the ordinary course of business consistent with past
    practices providing for payments by the Company or any of its
    Subsidiaries not in excess of $200,000&nbsp;per contract);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (k)&nbsp;the Company shall not make any new equity compensation
    awards (other than (x)&nbsp;any award of Company Stock Options
    that is made pursuant to an offer of employment that has been
    made prior to the date hereof, whether or not accepted as of the
    date hereof, and (y)&nbsp;any award of Company Stock Options
    that is made pursuant to an offer of employment that is made on
    or after the date hereof in the ordinary course of business
    consistent with past practice (any Company Stock Option
    described in clause&nbsp;(y), a <B>&#147;Specified Stock
    Option&#148;</B>)) or re-price (or effectively re-price through
    an option exchange or otherwise) any currently outstanding
    Company Stock Options, and shall not, and shall not permit any
    of its Subsidiaries to, enter into or amend any existing,
    employment, consultancy, deferred compensation, severance,
    retirement or other similar agreement with any director or
    employee, unless such agreement or amendment is (i)&nbsp;in the
    ordinary course consistent with past practice, (ii)&nbsp;in
    accordance with the approved 2005 business plan of the Company
    and its Subsidiaries or (iii)&nbsp;required to comply with
    applicable law (including amendments to non-qualified deferred
    compensation plans to the extent necessary to comply with
    Section&nbsp;409A of the Code) or the terms of any Employee Plan
    as in effect on the date hereof;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (l)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, (A)&nbsp;make or change any material election
    or method of accounting relating to Taxes, (B)&nbsp;file any
    amended Tax Return or claim for refund relating to material
    Taxes, (C)&nbsp;enter into any agreement with, or request a
    written ruling from, any Taxing Authority relating to material
    Taxes, or (D)&nbsp;compromise or settle any audit, appeal, suit,
    other proceeding relating to a material Tax liability or claim
    for refund;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">35

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (m)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to waive, release, assign, settle or compromise any
    material claims, or any material litigation or
    arbitration;&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (n)&nbsp;the Company shall not, and shall not permit any of its
    Subsidiaries to, agree or commit to do any of the foregoing.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='148'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 6.02. Stockholder Meeting; Proxy Material." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;6.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stockholder
Meeting; Proxy Material.</I> The Company shall cause a meeting
of its stockholders (the <B>&#147;Company Stockholder
Meeting&#148;</B>) to be duly called and held as soon as
reasonably practicable following the clearance of the Company
Proxy Statement by the SEC for the purpose of obtaining the
Company Stockholder Approval. Without limiting the generality of
the foregoing, the Company&#146;s obligations pursuant to the
preceding sentence shall not be affected by any Adverse
Recommendation Change. Notwithstanding the foregoing, if the
Company properly exercises its right to terminate this Agreement
pursuant to and in accordance with Section&nbsp;10.01(d), the
Company&#146;s obligations pursuant to the first sentence of
this Section&nbsp;6.02 shall terminate. Subject to
Section&nbsp;6.03(b), the Board of Directors of the Company
shall recommend adoption of this Agreement by the Company&#146;s
stockholders and shall not (i)&nbsp;recommend the approval or
adoption of any Acquisition Proposal, (ii)&nbsp;determine that
this Agreement or the Merger is no longer advisable,
(iii)&nbsp;withdraw or modify in any manner adverse to Parent or
Merger Subsidiary the recommendation of this Agreement, the
Merger or any of the other transactions contemplated hereby,
(iv)&nbsp;recommend that the stockholders of the Company reject
this Agreement, the Merger or any of the other transactions
contemplated hereby or (v)&nbsp;resolve, agree or propose
publicly to take any such actions (each such action being
referred to as an <B>&#147;Adverse Recommendation
Change&#148;</B>). In connection with the Company Stockholder
Meeting, the Company shall (i)&nbsp;promptly prepare and file
with the SEC, shall use its reasonable best efforts to have
cleared by the SEC and shall thereafter mail to its stockholders
as promptly as reasonably practicable the Company Proxy
Statement and all other proxy materials for the Company
Stockholder Meeting, (ii)&nbsp;use its reasonable best efforts
to obtain the Company Stockholder Approval and
(iii)&nbsp;otherwise comply with all legal requirements
applicable to such meeting.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='149'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 6.03. No Solicitation; Other Offers." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;6.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>No
Solicitation; Other Offers.</I> (a)&nbsp;Except as permitted by
Section&nbsp;6.03(b), neither the Company nor any of its
Subsidiaries shall, nor shall the Company or any of its
Subsidiaries authorize or permit any of its or their officers,
directors, employees, investment bankers, attorneys,
accountants, consultants or other agents or advisors to,
directly or indirectly, (i)&nbsp;solicit, initiate or take any
action to knowingly facilitate or encourage the submission of
any Acquisition Proposal, (ii)&nbsp;enter into or participate in
any discussions or negotiations with, furnish any nonpublic
information relating to the Company or any of its Subsidiaries
or afford access to the business, properties, assets, books or
records of the Company or any of its Subsidiaries to knowingly
facilitate, or otherwise cooperate in any way with, any Third
Party that has made, or has informed the Company of any
intention to make, or has publicly announced an <BR>
</DIV>

<P align="center" style="font-size: 10pt;">36

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">intention to make, an Acquisition Proposal,
(iii)&nbsp;(A)&nbsp;amend or grant any waiver or release under
any standstill or similar agreement with respect to any class of
equity securities of the Company or any of its Subsidiaries or
(B)&nbsp;approve any transaction under, or any Person becoming
an &#147;interested stockholder&#148; under, Section&nbsp;203 of
Delaware Law or (iv)&nbsp;enter into any agreement with respect
to an Acquisition Proposal (other than a confidentiality
agreement as contemplated by Section&nbsp;6.03(b)).</TD>
</TR>
</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;Notwithstanding the foregoing, the Company, directly or
    indirectly through advisors, agents or other intermediaries, may
    (i)&nbsp;engage in negotiations or discussions with any Third
    Party that, subject to the Company&#146;s compliance with
    Section&nbsp;6.03(a), has made an Acquisition Proposal that the
    Board of Directors of the Company has determined in good faith
    (after consultation with a financial advisor of nationally
    recognized reputation) constitutes a Superior Proposal or could
    reasonably be expected to lead to a Superior Proposal and/or
    (ii)&nbsp;furnish to such Third Party nonpublic information
    relating to the Company or any of its Subsidiaries pursuant to a
    confidentiality agreement with terms no less favorable to the
    Company than those contained in the Confidentiality Agreement
    dated October&nbsp;13, 2004 between Parent and the Company (the
    <B>&#147;Confidentiality Agreement&#148;</B>) (it being
    understood that such confidentiality agreement shall not be
    required to contain a standstill provision). Notwithstanding
    anything to the contrary in this Agreement, prior to receipt of
    the Company Stockholder Approval, the Board of Directors of the
    Company shall be permitted to make an Adverse Recommendation
    Change if the Board of Directors of the Company determines in
    good faith, after consultation with outside legal counsel to the
    Company, that it must take such action to comply with its
    fiduciary duties under applicable law. Nothing contained herein
    shall prevent the Board of Directors of the Company from
    complying with Rule&nbsp;14d-9 and Rule&nbsp;14e-2(a) under the
    1934 Act with regard to an Acquisition Proposal or otherwise
    making disclosure required by applicable law.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;The Board of Directors of the Company shall not take
    any of the actions referred to in Section&nbsp;6.03(b) unless
    the Company shall have delivered to Parent a prior written
    notice advising Parent that it intends to take such action. In
    addition, the Company shall notify Parent promptly (but in no
    event later than 24&nbsp;hours) after receipt by the Company (or
    any of its advisors) of any Acquisition Proposal or any request
    for nonpublic information relating to the Company or any of its
    Subsidiaries or for access to the business, properties, assets,
    books or records of the Company or any of its Subsidiaries by
    any Third Party that has made, or has informed the Company of
    any intention to make, or has publicly announced an intention to
    make, an Acquisition Proposal. The Company shall provide such
    notice orally and in writing and shall identify the Third Party
    making, and the material terms and conditions of, any such
    Acquisition Proposal or request. The Company shall keep Parent
    informed, on a current basis, of the status and details of any
    such Acquisition Proposal or request. The Company shall, and
    shall cause its Subsidiaries and the advisors, employees and
    other <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">37

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    agents of the Company and any of its Subsidiaries to, cease
    immediately and cause to be terminated any and all existing
    activities, discussions and negotiations, if any, with any Third
    Party conducted prior to the date hereof with respect to any
    Acquisition Proposal and shall use its reasonable best efforts
    to cause any such Third Party (or its agents or advisors) in
    possession of confidential information about the Company that
    was furnished by or on behalf of the Company to return or
    destroy all such information.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <B>&#147;Superior Proposal&#148;</B> means any bona fide,
    unsolicited written Acquisition Proposal (<I>provided </I>that
    for the purpose of this definition, each reference to
    &#147;20%&#148; in the definition of &#147;Acquisition
    Proposal&#148; shall be deemed to be a reference to
    &#147;50%&#148;) on terms that the Board of Directors of the
    Company determines in good faith after consulting with a
    financial advisor of nationally recognized reputation and taking
    into account all the terms and conditions of the Acquisition
    Proposal, including any break-up fees, expense reimbursement
    provisions, conditions to consummation and the likelihood and
    timing of consummation, are more favorable to the Company&#146;s
    stockholders than as provided hereunder and for which financing,
    to the extent required, is then fully committed or reasonably
    determined to be available by the Board of Directors of the
    Company.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='150'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 6.04. Access to Information." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;6.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Access
to Information.</I> From the date hereof until the Effective
Time and subject to applicable law, the Company shall
(i)&nbsp;give Parent, its counsel, financial advisors, auditors,
potential financing sources and other authorized representatives
reasonable access during normal business hours with reasonable
notice to the offices, properties, employees, books and records
of the Company and the Subsidiaries, (ii)&nbsp;furnish to
Parent, its counsel, financial advisors, auditors, potential
financing sources and other authorized representatives such
financial and operating data and other information as such
Persons may reasonably request and (iii)&nbsp;instruct the
employees, counsel, financial advisors, auditors and other
authorized representatives of the Company and its Subsidiaries
to cooperate with Parent in its investigation of the Company and
its Subsidiaries; <I>provided </I>that Parent shall not be
entitled to any data from the AIM Study prior to the time at
which any member of the senior management of the Company is
informed of such data. Any investigation pursuant to this
Section shall be conducted in such manner as not to interfere
unreasonably with the conduct of the business of the Company and
its Subsidiaries. No information or knowledge obtained by Parent
in any investigation pursuant to this Section shall affect or be
deemed to modify any representation or warranty made by the
Company hereunder. All information exchanged pursuant to
Section&nbsp;6.04 shall be provided pursuant to the terms of,
and be subject to, the Confidentiality Agreement.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='151'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 6.05. Voting of Shares of Parent Capital Stock." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;6.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Voting
of Shares of Parent Capital Stock.</I> The Company shall cause
the votes attaching to the ordinary shares of Parent
beneficially owned by it or any of its Subsidiaries to be cast
in favor of approval of the Merger at the Parent Shareholder
Meeting.
</DIV>

<P align="center" style="font-size: 10pt;">38

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='152'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 6.06. Notices of Certain Events." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;6.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notices
of Certain Events.</I> The Company shall promptly notify Parent
of:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;any notice or other communication from any Person
    alleging that the consent of such Person is or may be required
    in connection with the transactions contemplated by this
    Agreement;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;any material notice or other communication from any
    governmental or regulatory authority or agency in connection
    with the transactions contemplated by this Agreement;&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;any actions, suits, claims, investigations or
    proceedings commenced or, to its Knowledge, threatened against,
    relating to or involving or otherwise affecting the Company or
    any of its Subsidiaries that, if pending on the date of this
    Agreement, would have been required to have been disclosed
    pursuant to Section&nbsp;4.13, 4.14, 4.17 or 4.18, as the case
    may be, or that relate to the consummation of the transactions
    contemplated by the Transaction Agreements.</TD>
</TR>

</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;7
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Covenants of Parent
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Parent agrees that:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='153'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 7.01. Shareholder Meeting." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;7.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Shareholder
Meeting.</I> Parent shall cause a general meeting of its
shareholders (the <B>&#147;Parent Shareholder Meeting&#148;</B>)
to be duly called and held at substantially the same time as the
Company Stockholder Meeting for the purpose of voting on the
approval of the Merger in accordance with the applicable
requirements of the Listing Rules of the UK Listing Authority.
Notwithstanding the foregoing, if Parent makes a Change in
Parent Recommendation, Parent&#146;s obligations pursuant to the
first sentence of this Section&nbsp;7.01 shall terminate. The
Board of Directors of Parent shall recommend approval of the
Merger by Parent&#146;s shareholders and include such
recommendation in the Parent Shareholder Circular and shall not
(a)&nbsp;fail to make, withdraw or modify in a manner adverse to
the Company such recommendation, (b)&nbsp;recommend that the
shareholders of Parent reject the Merger or (c)&nbsp;resolve,
agree or publicly propose to take any such actions (each such
action being referred to as a <B>&#147;Change in Parent
Recommendation&#148;</B>). Notwithstanding anything in this
Agreement to the contrary, at any time prior to the Parent
Shareholder Meeting, the Board of Directors of Parent may if the
Board of Directors of Parent determines in good faith, after
consultation with outside counsel to Parent, that it must do so
to comply with its fiduciary duties under applicable law, make a
Change in Parent Recommendation. In connection with such
meeting, Parent shall (i)&nbsp;within a time frame consistent
with holding the Parent Shareholder Meeting at substantially the
same time as the Company Stockholder Meeting, prepare and then
file with the UK Listing Authority a draft copy of, shall use
its reasonable best efforts to have approved by the UK Listing
Authority and shall thereafter mail to its shareholders, the
Parent Shareholder <BR>
</DIV>

<P align="center" style="font-size: 10pt;">39

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
Circular, (ii)&nbsp;use its reasonable best efforts to obtain
the necessary approvals by its shareholders of this Agreement
and the Merger and (iii)&nbsp;otherwise comply with all legal
requirements applicable to such meeting.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='154'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 7.02. Obligations of Merger Subsidiary." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;7.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Obligations
of Merger Subsidiary.</I> Parent shall take all action necessary
to cause Merger Subsidiary to perform its obligations under this
Agreement and to consummate the Merger on the terms and
conditions set forth in this Agreement.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='155'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 7.03. Voting of Shares." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;7.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Voting
of Shares.</I> Parent shall vote all Shares beneficially owned
by it or any of its Subsidiaries in favor of adoption of this
Agreement at the Company Stockholder Meeting.
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <A name='156'></A></TD>
</TR>

</TABLE>

<!-- link1 "Section 7.04. Director and Officer Liability." -->

<DIV align="left" style="font-size: 10pt;">
<FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;7.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Director
and Officer Liability.</I> Parent shall cause the Surviving
Corporation, and the Surviving Corporation hereby agrees, to do
the following:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;The Surviving Corporation shall, and Parent shall and
    shall cause the Surviving Corporation to, indemnify and hold
    harmless the present and former officers and directors of the
    Company (each an <B>&#147;Indemnified Person&#148;</B>) in
    respect of acts or omissions occurring at or prior to the
    Effective Time to the fullest extent permitted by Delaware Law
    or any other applicable laws or provided under the
    Company&#146;s certificate of incorporation and bylaws in effect
    on the date hereof; <I>provided </I>that such indemnification
    shall be subject to any limitation imposed from time to time
    under applicable law.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;For six years after the Effective Time, the Surviving
    Corporation shall maintain in effect the current policies of
    directors&#146; and officers&#146; liability insurance
    maintained by the Company (<I>provided </I>that Parent may
    substitute therefor policies with reputable and financially
    sound carriers of at least the same coverage and amounts
    containing terms and conditions which are no less advantageous
    in the aggregate) with respect to claims arising from or related
    to facts or events which occurred at or before the Effective
    Time; <I>provided </I>that, in satisfying its obligation under
    this Section&nbsp;7.04(b), the Surviving Corporation shall not
    be obligated to pay premiums in excess of 250% of the amount per
    annum the Company paid in its last full fiscal year prior to the
    date of this Agreement, which amount the Company has disclosed
    to Parent prior to the date hereof; and <I>provided further
    </I>that if the annual premiums of such insurance coverage
    exceed such amount, the Surviving Corporation shall be obligated
    to obtain a policy with the greatest coverage available, with
    respect to matters occurring prior to the Effective Time, for a
    cost not exceeding such amount.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;If Parent, the Surviving Corporation or any of their
    successors or assigns (i)&nbsp;consolidates with or merges into
    any other Person and shall not be the continuing or surviving
    corporation or entity of such consolidation or merger, or
    (ii)&nbsp;transfers or conveys all or substantially all of its
    properties and assets to any Person, then, and in each such
    case, proper provision shall be made so that the <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">40

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    successors and assigns of Parent or the Surviving Corporation,
    as the case may be, shall assume the obligations set forth in
    this Section&nbsp;7.04.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;The rights of each Indemnified Person under this
    Section&nbsp;7.04 shall be in addition to, and not in limitation
    of, any rights to indemnification and exculpation of personal
    liability that such Person may have under the certificate of
    incorporation or bylaws of the Company or any of its
    Subsidiaries, or under Delaware Law or any other applicable laws
    or under any agreement of any Indemnified Person with the
    Company or any of its Subsidiaries. These rights shall survive
    consummation of the Merger and are expressly intended to
    benefit, and shall be enforceable by, each Indemnified Person,
    his or her heirs and his or her personal representatives.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='157'></A>
</DIV>

<!-- link1 "Section 7.05. Employee Matters." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;7.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Employee
    Matters.</I> (a)&nbsp;During the period from the Effective Time
    through the first anniversary thereof, Parent shall, and shall
    cause its Subsidiaries to, provide to each individual employed
    by the Company or any of its Subsidiaries immediately prior to
    the Effective Time (a <B>&#147;Continuing Employee&#148;</B>)
    compensation and benefits that are no less favorable in the
    aggregate than those provided to such Continuing Employee by the
    Company and its Subsidiaries immediately prior to the Effective
    Time. Without limiting the generality of the foregoing, Parent
    shall continue and maintain the Company&#146;s 2005 Management
    Bonus Plan on behalf of Continuing Employees in accordance with
    its terms and conditions in effect as of the date hereof and
    shall pay any amounts due thereunder in respect of the 2005
    performance year in accordance with such terms, and for the 2006
    performance year and subsequent performance years, Continuing
    Employees shall participate in the bonus plans of Parent as in
    effect from time to time. For the avoidance of doubt, nothing in
    this Agreement shall constitute an express or implied promise of
    continued employment for any period or at all and will not
    interfere in any way with an employer&#146;s right to dismiss a
    Continuing Employee from employment at any time, with or without
    cause.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;The service of each Continuing Employee with the
    Company or its Subsidiaries (or any predecessor employer) prior
    to the Effective Time shall be treated as service with Parent
    and its Subsidiaries for all purposes under each Employee Plan,
    International Plan or similar plan, program or arrangement in
    which such Continuing Employee is eligible to participate after
    the Effective Time (<B>&#147;Continuing Employee
    Plans&#148;</B>), except as otherwise limited or prohibited by
    applicable law, statute, ordinance, rule or regulation or the
    terms of such plan (<I>provided </I>that no such term shall
    apply to Continuing Employees differently than other similarly
    situated employees of Parent).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;Following the Effective Time, for purposes of each
    Continuing Employee Plan that provides employee welfare
    benefits, Parent shall, and shall cause its Subsidiaries to,
    (i)&nbsp;waive any pre-existing condition, exclusion,
    actively-at-work requirement, waiting period or similar
    limitation and (ii)&nbsp;provide full <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">41

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    credit for any co-payments, deductibles or similar payments made
    or incurred by each Continuing Employee prior to the Effective
    Time.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;Parent shall, and shall cause its Subsidiaries to,
    honor each Company Employee Plan and Company International Plan
    in accordance with its terms and all obligations thereunder that
    have accrued as of the Effective Time, including obligations
    with respect to vacation, severance agreements as set forth in
    Section&nbsp;7.05(d) of the Company Disclosure Schedule, sick
    leave and paid time off. For the avoidance of doubt, nothing in
    this Agreement is intended to prevent Parent from amending,
    suspending or terminating any such Company Employee Plan or
    Company International Plan in accordance with its terms, or
    causing a Subsidiary of Parent to effect such an amendment,
    suspension or termination.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;Without limiting the generality of
    Section&nbsp;7.05(a), Parent and the Company, as applicable,
    shall provide to the employees of the Company and its
    Subsidiaries the retention, severance and other benefits set
    forth in Schedule&nbsp;7.05(e) to this Agreement. Prior to the
    Effective Time, Parent and the Company shall cooperate in good
    faith (i)&nbsp;to prepare the plans, programs and other
    documents necessary or appropriate to provide such benefits;
    <I>provided </I>that the Company shall not make any general
    communication regarding such plans, programs, documents or
    benefits to the employees of the Company and its Subsidiaries
    without obtaining the prior approval of Parent (such approval
    not to be unreasonably withheld or delayed) and (ii)&nbsp;to
    prepare any reports or other filings with the SEC required to
    disclose any such benefits within any applicable SEC deadlines.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='158'></A>
</DIV>

<!-- link1 "Section 7.06. Conduct of Parent." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section&nbsp;7.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Conduct
    of Parent.</I> Between the date of this Agreement and the
    Effective Time, neither Parent nor any of its Affiliates shall
    acquire, or agree to acquire, whether in the open market or
    otherwise, any rights in any equity securities of the Company
    other than pursuant to the Merger. During the period from the
    date of this Agreement to the earlier of the Effective Time and
    the termination of this Agreement in accordance with the terms
    hereof, except as consented to in writing by the Company, none
    of Parent or any of its Subsidiaries shall make any material
    acquisition that is reasonably likely to (a)&nbsp;materially
    impair Parent&#146;s ability to consummate the transactions
    contemplated by the Transaction Agreements or (b)&nbsp;cause a
    material delay of the Merger.</TD>
</TR>

</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;8
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Covenants of Parent and
the Company
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The parties hereto agree that:
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='159'></A>
</DIV>

<!-- link1 "Section 8.01. Reasonable Best Efforts." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;8.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Reasonable
    Best Efforts.</I> (a)&nbsp;Subject to the terms and conditions
    of this Agreement, the Company and Parent shall use their
    reasonable best efforts to take, or cause to be taken, all
    actions and to do, or cause to be done, all things necessary,
    proper or advisable under applicable laws and regulations to <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">42

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    consummate the transactions contemplated by the Transaction
    Agreements, including (i)&nbsp;preparing and filing as promptly
    as practicable with any governmental authority or other third
    party all documentation to effect all necessary filings,
    notices, petitions, statements, registrations, submissions of
    information, applications and other documents and
    (ii)&nbsp;obtaining and maintaining all approvals, consents,
    registrations, permits, authorizations and other confirmations
    required to be obtained from any governmental authority or other
    third party that are necessary, proper or advisable to
    consummate the transactions contemplated by the Transaction
    Agreements. Parent and the Company shall, from the date hereof
    until the End Date, use their reasonable best efforts to resist
    the entry of, or to have vacated or terminated, any judgment,
    injunction, order or decree that would restrain, prevent or
    delay the Effective Time.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;In furtherance and not in limitation of the foregoing,
    each of Parent and the Company shall make an appropriate filings
    of Notification and Report Forms pursuant to the HSR Act with
    respect to the transactions contemplated by the Transaction
    Agreements as promptly as practicable and in any event within 15
    Business Days of the date hereof and to supply as promptly as
    practicable any additional information and documentary material
    that may be requested pursuant to the HSR Act and to take all
    other actions necessary to cause the expiration or termination
    of the applicable waiting periods under the HSR Act as soon as
    practicable.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='160'></A>
</DIV>

<!-- link1 "Section 8.02. Certain Filings." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;8.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certain
    Filings.</I> The Company and Parent shall cooperate with one
    another (i)&nbsp;in connection with the preparation of the
    Company Proxy Statement and the Parent Shareholder Circular,
    (ii)&nbsp;in determining whether any action by or in respect of,
    or filing with, any governmental authority is required in
    connection with the consummation of the transactions
    contemplated by the Transaction Agreements and (iii)&nbsp;in
    taking such actions or making any such filings, furnishing
    information required in connection therewith or with the Company
    Proxy Statement or the Parent Shareholder Circular and seeking
    to obtain in a timely manner any consents and approvals required
    in connection with the consummation of the transactions
    contemplated by the Transaction Agreements.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='161'></A>
</DIV>

<!-- link1 "Section 8.03. Public Announcements." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;8.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Public
    Announcements.</I> Parent and the Company shall consult with
    each other before issuing any press release or making any other
    public statement, or scheduling any press conference or
    conference call with investors or analysts, with respect to this
    Agreement or the transactions contemplated hereby and, except as
    may be required by applicable law, order of a court of competent
    jurisdiction or any listing agreement with or rule of any
    securities exchange or association, shall not issue any such
    press release or make any such other public statement or
    schedule any such press conference or conference call before
    such consultation.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='162'></A>
</DIV>

<!-- link1 "Section 8.04. Further Assurances." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;8.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Further
    Assurances.</I> At and after the Effective Time, the officers
    and directors of the Surviving Corporation shall be authorized
    to execute <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">43

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    and deliver, in the name and on behalf of the Company or Merger
    Subsidiary, any deeds, bills of sale, assignments or assurances
    and to take and do, in the name and on behalf of the Company or
    Merger Subsidiary, any other actions and things to vest, perfect
    or confirm of record or otherwise in the Surviving Corporation
    any and all right, title and interest in, to and under any of
    the rights, properties or assets of the Company acquired or to
    be acquired by the Surviving Corporation as a result of, or in
    connection with, the Merger.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='163'></A>
</DIV>

<!-- link1 "Section 8.05. Employee Communications." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section&nbsp;8.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Employee
    Communications.</I> Parent and the Company shall cooperate in
    good faith to permit, subject to applicable law, Parent to send
    or make available written notices and other communication
    materials to the employees of the Company or any Subsidiary
    thereof; <I>provided </I>that Parent shall consult with the
    Company (and consider in good faith the advice of the Company),
    and shall obtain the prior approval of the Company (such
    approval not to be unreasonably withheld or delayed).</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='164'></A>
</DIV>

<!-- link1 "Section 8.06. Amendments to Dynepo License Agreement." -->

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT style="font-variant:SMALL-CAPS">Section</FONT>&nbsp;8.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
    to Dynepo License Agreement.</I> The Company and Parent will
    discuss in good faith until May&nbsp;20, 2005 any modifications
    to the Dynepo License Agreement reasonably requested in writing
    by either party; <I>provided </I>that in the event that such
    modifications are not mutually agreed by such date, the Dynepo
    License Agreement as executed on the date of this Agreement will
    remain in effect on its original terms, subject to the
    conditions to its effectiveness set forth in
    Section&nbsp;11.04(e) below.</TD>
</TR>

</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;9
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Conditions to the Merger
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='165'></A>
</DIV>

<!-- link1 "Section 9.01. Conditions to Obligations of Each Party." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Conditions
to Obligations of Each Party.</I> The obligations of the
Company, Parent and Merger Subsidiary to consummate the Merger
are subject to the satisfaction of the following conditions:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;the Company shall have obtained the Company Stockholder
    Approval;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;no provision of any applicable law or regulation and no
    judgment, injunction, order or decree of a governmental
    authority of competent jurisdiction shall prohibit the
    consummation of the Merger;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;any applicable waiting period under the HSR Act
    relating to the Merger shall have expired or been
    terminated;&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;the Merger shall have been approved by the shareholders
    of Parent in accordance with the requirements of the Listing
    Rules of the UK Listing Authority.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">44

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
<A name='166'></A>
</DIV>

<!-- link1 "Section 9.02. Conditions to the Obligations of Parent and Merger Subsidiary." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;9.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Conditions
to the Obligations of Parent and Merger Subsidiary.</I> The
obligations of Parent and Merger Subsidiary to consummate the
Merger are subject to the satisfaction or waiver (to the extent
permitted by applicable law) of the following further conditions:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;(i)&nbsp;the Company shall have performed in all
    material respects all of its material obligations hereunder
    required to be performed by it at or prior to the Effective
    Time, (ii)&nbsp;the representations and warranties of the
    Company contained in this Agreement (other than those set forth
    in clause&nbsp;(iii) below), disregarding all materiality and
    Company Material Adverse Effect qualifications contained
    therein, shall be true and correct on and as of the Closing
    Date, other than representations and warranties that by their
    terms address matters only as of another specified time, which,
    disregarding all materiality and Company Material Adverse Effect
    qualifications contained therein, shall be true and correct only
    as of such time, in each case, with only such exceptions as have
    not had, and are not reasonably likely to have, individually or
    in the aggregate, a Company Material Adverse Effect,
    (iii)&nbsp;the representations and warranties of the Company set
    forth in Sections&nbsp;4.01, 4.02, 4.05 and 4.23, disregarding
    all materiality and Company Material Adverse Effect
    qualifications contained therein, shall be true and correct in
    all material respects on and as of the Closing Date, other than
    representations and warranties that by their terms address
    matters only as of another specified time, which, disregarding
    all materiality and Company Material Adverse Effect
    qualifications contained therein, shall be true and correct in
    all material respects only as of such time, and (iv)&nbsp;Parent
    shall have received a certificate signed by an executive officer
    of the Company to the foregoing effect;&nbsp;and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;there shall not be pending any action or proceeding by
    any government or governmental authority or agency, domestic,
    foreign or supranational, before any court or governmental
    authority or agency, domestic, foreign or supranational, of a
    jurisdiction in which a material portion of the business or
    assets of the Company and its Subsidiaries, taken as a whole, or
    Parent and its Subsidiaries, taken as a whole, is located
    (i)&nbsp;challenging or seeking to make illegal or to restrain
    or prohibit the consummation of the Merger or (ii)&nbsp;seeking
    to restrain or prohibit Parent&#146;s ownership or operation (or
    that of its respective Subsidiaries) of all or any material
    portion of the business or assets of the Company and its
    Subsidiaries, taken as a whole, or of Parent and its
    Subsidiaries, taken as a whole, or to compel Parent or any of
    its Subsidiaries or Affiliates to dispose of or hold separate
    all or any material portion of the business or assets of the
    Company and its Subsidiaries, taken as a whole, or of Parent and
    its Subsidiaries, taken as a whole.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;the holders of not more than 15% of the Shares shall
    have demanded appraisal of their shares in accordance with
    Delaware Law.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt;">
<A name='167'></A>
</DIV>

<!-- link1 "Section 9.03. Conditions to the Obligations of the Company." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Section&nbsp;9.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Conditions to
the Obligations of the Company.</I> The obligations of the
Company to consummate the Merger are subject to the satisfaction
or waiver (to the extent permitted by applicable law) of the
following <BR>
</DIV>

<P align="center" style="font-size: 10pt;">45

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
further conditions: (a)&nbsp;each of Parent and Merger
Subsidiary shall have performed in all material respects all of
its material obligations hereunder required to be performed by
it at or prior to the Effective Time, (b)&nbsp;the
representations and warranties of Parent contained in this
Agreement (other than those set forth in clause&nbsp;(c) below),
disregarding all materiality and Parent Material Adverse Effect
qualifications contained therein, shall be true and correct on
and as of the Closing Date, other than representations and
warranties that by their terms address matters only as of
another specified time, which, disregarding all materiality and
Parent Material Adverse Effect qualifications contained therein,
shall be true and correct only as of such time, in each case,
with only such exceptions as, individually or in the aggregate,
have not had and are not reasonably likely to have a Parent
Material Adverse Effect, (c)&nbsp;the representations and
warranties of Parent set forth in Sections&nbsp;5.01 and 5.02,
disregarding all materiality and Parent Material Adverse Effect
qualifications contained therein, shall be true and correct in
all material respects on and as of the Closing Date, other than
representations and warranties that by their terms address
matters only as of another specified time, which, disregarding
all materiality and Parent Material Adverse Effect
qualifications contained therein, shall be true and correct in
all material respects only as of such time and (d)&nbsp;the
Company shall have received a certificate signed by an executive
officer of Parent to the foregoing effect.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;10
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Termination
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='168'></A>
</DIV>

<!-- link1 "Section 10.01. Termination." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Section&nbsp;10.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination.</I>
This Agreement may be terminated and the Merger may be abandoned
at any time prior to the Effective Time (notwithstanding receipt
of the Company Stockholder Approval and/or any approval of this
Agreement by the shareholders of Parent):
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (a)&nbsp;by mutual written agreement of the Company and Parent;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (b)&nbsp;by either the Company or Parent, if:</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (i)&nbsp;the Merger has not been consummated on or before
    December&nbsp;31, 2005 (the <B>&#147;End Date&#148;</B>);
    <I>provided </I>that the right to terminate this Agreement
    pursuant to this Section&nbsp;10.01(b)(i) shall not be available
    to any party whose breach of any provision of this Agreement
    results in the failure of the Merger to be consummated by such
    time;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (ii)&nbsp;(A)&nbsp;there shall be any law or regulation that
    makes consummation of the Merger illegal or otherwise prohibited
    or (B)&nbsp;any judgment, injunction, order or decree of any
    court or governmental body having competent jurisdiction
    enjoining the Company, Parent or Merger Subsidiary from
    consummating the Merger is entered and such judgment,
    injunction, order or decree shall have become final and
    nonappealable;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">46

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="6%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (iii)&nbsp;the Company Stockholder Approval shall not have been
    obtained at the Company Stockholder Meeting (or any adjournment
    thereof);&nbsp;or</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (iv)&nbsp;the Merger shall not have been approved in accordance
    with the requirements of the Listing Rules of the UK Listing
    Authority by Parent&#146;s shareholders at the Parent
    Shareholder Meeting (or any adjournment thereof);</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (c)&nbsp;by Parent, if the Board of Directors of the Company
    shall have made an Adverse Recommendation Change or shall have
    failed to call and hold the Company Stockholder Meeting in
    accordance with Section&nbsp;6.02;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (d)&nbsp;by the Company prior to the receipt of the Company
    Stockholder Approval; <I>provided </I>that (i)&nbsp;the Company
    notifies Parent, in writing at least 48&nbsp;hours falling
    within two Business Days prior to such termination, of its
    intention to terminate this Agreement and to enter into a
    binding written agreement concerning an Acquisition Proposal
    that constitutes a Superior Proposal (a <B>&#147;Competing
    Proposal&#148;</B>), attaching the most current version of such
    agreement (or a description of all material terms and conditions
    thereof), and (ii)&nbsp;Parent does not make, within
    48&nbsp;hours falling within two Business Days of receipt of
    such written notification, a binding written offer (a
    <B>&#147;New Offer&#148;</B>) to amend the terms of this
    Agreement to include terms that are at least as favorable to the
    stockholders of the Company as such Competing Proposal, it being
    understood that the Company shall not enter into any such
    binding agreement during such 48-hour period; and <I>provided
    further </I>that the Company shall have paid any amounts due
    pursuant to Section&nbsp;11.04 in accordance with its terms. If
    Parent shall have made a New Offer as contemplated by the
    foregoing clause&nbsp;(ii), then the Company may not terminate
    this Agreement pursuant to this Section&nbsp;10.01(d) unless the
    Board of Directors of the Company shall have determined in good
    faith, after consultation with a financial advisor of nationally
    recognized reputation and taking into account all the terms and
    conditions of such Competing Proposal, including any break-up
    fees, expense reimbursement provisions, conditions to
    consummation and the likelihood and timing of consummation, that
    the terms of such Competing Proposal are more favorable than the
    terms of such New Offer;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (e)&nbsp;by Parent, if a breach of any representation or
    warranty or failure to perform any covenant or agreement on the
    part of the Company set forth in this Agreement shall have
    occurred that would cause the condition set forth in
    Section&nbsp;9.02(a) not to be satisfied, and as a result of
    such breach such condition is incapable of being satisfied by
    the End Date or the Company shall have willfully and materially
    breached any of its obligations under Section&nbsp;6.02 or
    Section&nbsp;6.03;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (f)&nbsp;by the Company, if a breach of any representation or
    warranty or failure to perform any covenant or agreement on the
    part of the Parent or Merger Subsidiary set forth in this
    Agreement shall have occurred that would cause the <BR></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">47

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    condition set forth in Section&nbsp;9.03 not to be
    satisfied, and as a result of such breach such condition is
    incapable of being satisfied by the End Date;&nbsp;or</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (g)&nbsp;by the Company, if the Board of Directors of Parent
    shall have made a Change in Parent Recommendation or shall have
    failed to call and hold the Parent Shareholder Meeting in
    accordance with Section&nbsp;7.01.</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
The party desiring to terminate this Agreement pursuant to this
Section&nbsp;10.01 (other than pursuant to
Section&nbsp;10.01(a)) shall give notice of such termination to
the other party.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='169'></A>
</DIV>

<!-- link1 "Section 10.02. Effect of Termination." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;10.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Effect
of Termination.</I> If this Agreement is terminated pursuant to
Section&nbsp;10.01, this Agreement shall become void and of no
effect without liability of any party (or any stockholder,
director, officer, employee, agent, consultant or representative
of such party) to the other party hereto; <I>provided </I>that,
if such termination shall result from the willful failure of
either party to perform a covenant hereof, such party shall be
fully liable for any and all liabilities and damages incurred or
suffered by the other party as a result of such failure. The
provisions of this Section&nbsp;10.02 and Sections&nbsp;11.04,
11.06, 11.07 and 11.08 shall survive any termination hereof
pursuant to Section&nbsp;10.01 and, in addition,
Section&nbsp;8.01 (to the extent relating to the License
Agreement) and Section&nbsp;11.12 (to the extent provided in
Section&nbsp;11.04) shall survive any Qualifying Termination.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
ARTICLE&nbsp;11
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
<FONT style="font-variant:SMALL-CAPS">Miscellaneous
</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='170'></A>
</DIV>

<!-- link1 "Section 11.01. Notices." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Notices.</I>
All notices, requests and other communications to any party
hereunder shall be in writing (including facsimile transmission)
and shall be given,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
if to Parent or Merger Subsidiary, to:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Shire Pharmaceuticals Group plc</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Hampshire International Business Park</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Chineham Basingstoke</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Hampshire RG24 8EP</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    United Kingdom</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Attention: Tatjana May, General Counsel</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Facsimile No.: +44 (0)&nbsp;12 5689 4710</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">48

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
with a copy to:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Davis Polk&nbsp;&#38; Wardwell</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    450 Lexington Avenue</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    New York, New York 10017</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    &nbsp;Attention: John J. McCarthy,&nbsp;Jr.</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Leonard
    Kreynin</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Facsimile No.: (212)&nbsp;450-3800</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
if to the Company, to:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Transkaryotic Therapies, Inc.</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    700 Main Street</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Cambridge, MA 02139</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Attention: Tamara Jones</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Facsimile No.: (617)&nbsp;613-4402</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
with a copy to:
</DIV>

<DIV style="margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Wilmer Cutler Pickering Hale and Dorr LLP</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    60 State Street</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Boston, Massachusetts 02109</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Attention: David E. Redlick</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Facsimile No.: (617)&nbsp;526-5000</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Cravath, Swaine&nbsp;&#38; Moore LLP</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Worldwide Plaza</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    825 Eighth Avenue</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    New York, N.Y. 10019-7475</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Attention: Faiza Saeed</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    Facsimile No.: (212)&nbsp;474-3700</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">
or to such other address or facsimile number as such party may
hereafter specify for the purpose by notice to the other parties
hereto. All such notices, requests and other communications
shall be deemed received on the date of receipt by the recipient
thereof if received prior to 5:00&nbsp;p.m. on a Business Day in
the place of receipt. Otherwise, any such notice, request or
communication shall be deemed to have been received on the next
succeeding Business Day in the place of receipt.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='171'></A>
</DIV>

<!-- link1 "Section 11.02. Survival of Representations and Warranties." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Survival
of Representations and Warranties.</I> The representations,
warranties, covenants and other agreements contained herein and
in any certificate or other writing delivered pursuant hereto,
including any rights arising out of any breach of such
representations, warranties, covenants and other agreements,
shall not survive the Effective Time. This Section&nbsp;11.02
shall not, however, limit any covenant or agreement set forth in
Section&nbsp;7.04 of this <BR>
</DIV>

<P align="center" style="font-size: 10pt;">49

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
Agreement, which by its terms contemplates performance after the
Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='172'></A>
</DIV>

<!-- link1 "Section 11.03. Amendments and Waivers." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.03.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Amendments
and Waivers.</I> (a)&nbsp;Any provision of this Agreement may be
amended or waived prior to the Effective Time if, but only if,
such amendment or waiver is in writing and is signed, in the
case of an amendment, by each party to this Agreement or, in the
case of a waiver, by each party against whom the waiver is to be
effective; <I>provided </I>that, after the adoption of this
Agreement by the stockholders of the Company and without their
further approval, no such amendment or waiver shall reduce the
amount or change the kind of consideration to be received in
exchange for the Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;No failure or delay by any party in exercising any
right, power or privilege hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof
preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. The rights and remedies
herein provided shall be cumulative and not exclusive of any
rights or remedies provided by law.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='173'></A>
</DIV>

<!-- link1 "Section 11.04. Expenses." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.04.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Expenses.</I>
(a)&nbsp;Except as otherwise provided herein, all costs and
expenses incurred in connection with this Agreement shall be
paid by the party incurring such cost or expense.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;If a Company Payment Event occurs, the Company shall
pay Parent (by wire transfer of immediately available funds), if
pursuant to (x)&nbsp;below, simultaneously with the occurrence
of such Company Payment Event or, if pursuant to (y)&nbsp;below,
within two Business Days following such Company Payment Event, a
fee of $52,000,000; <I>provided </I>that if the Company Payment
Event occurred solely as a result of a transfer, sale, lease,
license or other transaction involving a material portion of the
assets licensed under the Dynepo License Agreement being deemed
an &#147;Acquisition Proposal&#148; pursuant to
clause&nbsp;(z)&nbsp;of the definition of &#147;Company Payment
Event,&#148; then the fee shall be reduced to $16,000,000.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
A <B>&#147;Company Payment Event&#148;</B> shall be deemed to
have occurred if (x)&nbsp;this Agreement shall have been
terminated pursuant to Section&nbsp;10.01(c) or
Section&nbsp;10.01(d), (y)&nbsp;within 12&nbsp;months of the
termination of this Agreement pursuant to
Section&nbsp;10.01(b)(i), the Company shall have entered into a
definitive written agreement with respect to, recommended to its
stockholders or consummated, an Acquisition Proposal if prior to
such termination there shall have been made an Acquisition
Proposal (<I>provided </I>that solely for purposes of this
clause&nbsp;(y), the term &#147;Acquisition Proposal&#148; shall
have the meaning set forth in Section&nbsp;1.01(a), except that
all references to &#147;20%&#148; shall be deemed references to
&#147;45%&#148;) or (z)&nbsp;within 12&nbsp;months of the
termination of this Agreement pursuant to
Section&nbsp;10.01(b)(iii), the Company shall have entered into
a definitive written agreement with respect to, recommended to
its stockholders or consummated, an Acquisition Proposal if
prior to the Company Stockholder Meeting there shall have been
made an Acquisition Proposal (<I>provided </I>that solely for
purposes of this <BR>
</DIV>

<P align="center" style="font-size: 10pt;">50

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
clause&nbsp;(z), the term &#147;Acquisition Proposal&#148; shall
have the meaning set forth in Section&nbsp;1.01(a), except that
all references to &#147;20%&#148; shall be deemed references to
&#147;33a%,&#148; and it is understood that, for the purposes of
this clause&nbsp;(z), any transfer, sale, lease, license or
other transaction involving a material portion of the assets
licensed under the Dynepo License Agreement shall be deemed an
&#147;Acquisition Proposal&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(c)&nbsp;If a Parent Payment Event occurs, Parent shall pay the
Company (by wire transfer of immediately available funds) within
two Business Days following such Parent Payment Event, a fee of
$40,000,000. A <B>&#147;Parent Payment Event&#148;</B> shall be
deemed to have occurred if this Agreement shall have been
terminated by either Parent or the Company pursuant to
Section&nbsp;10.01(b)(iv) or by the Company pursuant to
Section&nbsp;10.01(g).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(d)&nbsp;If a Company Payment Event occurs, the Company shall
reimburse Parent and its Affiliates (by wire transfer of
immediately available funds), no later than two Business Days
after such termination, for 100% of their documented
out-of-pocket fees and expenses (including reasonable fees and
expenses of their counsel) up to $4,000,000 actually incurred by
any of them in connection with this Agreement and the
transactions contemplated hereby, including the arrangement of,
obtaining the commitment to provide or obtaining any financing
for such transactions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(e)&nbsp;If this Agreement is terminated pursuant to
Section&nbsp;10.01 in a Qualifying Termination, the Dynepo
License Agreement shall become effective immediately thereafter
and the payment described in Section&nbsp;6.1 of the Dynepo
License Agreement shall be immediately due and shall be payable
(by wire transfer of immediately available funds) no later than
two Business Days after such Qualifying Termination. For the
avoidance of doubt, any disputes as to the effectiveness of the
Dynepo License Agreement or the payment described in
Section&nbsp;6.1 of the Dynepo License Agreement shall be
governed by Sections&nbsp;11.07, 11.08 and 11.12 of this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(f)&nbsp;Each party acknowledges that the agreements contained
in this Section&nbsp;11.04 are an integral part of the
transactions contemplated by this Agreement and that, without
these agreements, it would not enter into this Agreement.
Accordingly, if any party fails promptly to pay any amount due
to the other party pursuant to this Section&nbsp;11.04, it shall
also pay any costs and expenses incurred by such other party in
connection with a legal action to enforce this Agreement that
results in a judgment against such Party for such amount.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='174'></A>
</DIV>

<!-- link1 "Section 11.05. Binding Effect; Benefit; No Third Party Beneficiaries; Assignment." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.05.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Binding
Effect; Benefit; No Third Party Beneficiaries; Assignment.</I>
(a)&nbsp;The provisions of this Agreement shall be binding upon
and, except as provided in Section&nbsp;7.04, shall inure to the
benefit of the parties hereto and their respective successors
and assigns. Except as provided in Section&nbsp;7.04, no
provision of this Agreement is intended to confer any rights,
benefits, <BR>
</DIV>

<P align="center" style="font-size: 10pt;">51

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
remedies, obligations or liabilities hereunder upon any Person
other than the parties hereto and their respective successors
and assigns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(b)&nbsp;No party may assign, delegate or otherwise transfer any
of its rights or obligations under this Agreement without the
consent of each other party hereto, except that Merger
Subsidiary may transfer or assign, in whole or from time to time
in part, to another wholly owned Subsidiary of Parent the right
to enter into the transactions contemplated by this Agreement,
but any such transfer or assignment shall not relieve Parent or
Merger Subsidiary of its obligations hereunder. Any purported
assignment without such consent shall be void.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='175'></A>
</DIV>

<!-- link1 "Section 11.06. Governing Law." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.06.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Governing
Law.</I> This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware, without
regard to the conflicts of law rules of such state.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='176'></A>
</DIV>

<!-- link1 "Section 11.07. Jurisdiction." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.07.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Jurisdiction.</I>
The parties hereto agree that any suit, action or proceeding
seeking to enforce any provision of, or based on any matter
arising out of or in connection with, this Agreement or the
transactions contemplated hereby shall be brought in any federal
court located in the State of Delaware or any Court of Chancery
in New Castle County in the State of Delaware, and each of the
parties hereby irrevocably submits to the jurisdiction of such
courts (and of the appropriate appellate courts therefrom) in
any such suit, action or proceeding and irrevocably waives, to
the fullest extent permitted by law, any objection that it may
now or hereafter have to the laying of the venue of any such
suit, action or proceeding in any such court or that any such
suit, action or proceeding brought in any such court has been
brought in an inconvenient forum. Process in any such suit,
action or proceeding may be served on any party anywhere in the
world, whether within or without the jurisdiction of any such
court. Without limiting the foregoing, each party agrees that
service of process on such party as provided in
Section&nbsp;11.01 shall be deemed effective service of process
on such party.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='177'></A>
</DIV>

<!-- link1 "Section 11.08. WAIVER OF JURY TRIAL." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.08.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>WAIVER
OF JURY TRIAL.</I> EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY
WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='178'></A>
</DIV>

<!-- link1 "Section 11.09. Counterparts; Effectiveness." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.09.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Counterparts;
Effectiveness.</I> This Agreement may be signed in any number of
counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the
same instrument. This Agreement shall become effective when each
party hereto shall have received a counterpart hereof signed by
all of the other parties hereto. Until and unless each party has
received a counterpart hereof signed by the other party hereto,
this Agreement shall have no effect and no party shall have any
right or obligation hereunder (whether by virtue of any other
oral or written agreement or other communication).
</DIV>

<P align="center" style="font-size: 10pt;">52

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt;">
<A name='179'></A>
</DIV>

<!-- link1 "Section 11.10. Entire Agreement." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Entire
Agreement.</I> This Agreement, the Confidentiality Agreement and
the License Agreement constitute the entire agreement between
the parties with respect to the subject matter hereof and
thereof and supersede all prior agreements and understandings,
both oral and written, between the parties with respect to the
subject matter hereof and thereof.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='180'></A>
</DIV>

<!-- link1 "Section 11.11. Severability." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Severability.</I>
If any term, provision, covenant or restriction of this
Agreement is held by a court of competent jurisdiction or other
authority to be invalid, void or unenforceable, the remainder of
the terms, provisions, covenants and restrictions of this
Agreement shall remain in full force and effect and shall in no
way be affected, impaired or invalidated so long as the economic
or legal substance of the transactions contemplated hereby is
not affected in any manner materially adverse to any party. Upon
such a determination, the parties shall negotiate in good faith
to modify this Agreement so as to effect the original intent of
the parties as closely as possible in an acceptable manner in
order that the transactions contemplated hereby be consummated
as originally contemplated to the fullest extent possible.
</DIV>

<DIV align="left" style="font-size: 10pt;">
<A name='181'></A>
</DIV>

<!-- link1 "Section 11.12. Specific Performance." -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT style="font-variant:SMALL-CAPS">Section&nbsp;11.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Specific
Performance.</I> The parties hereto agree that irreparable
damage would occur if any provision of this Agreement were not
performed in accordance with the terms hereof and that the
parties shall be entitled to an injunction or injunctions to
prevent breaches of this Agreement or to enforce specifically
the performance of the terms and provisions hereof in any
federal court located in the State of Delaware or the Court of
Chancery in New Castle County in the State of Delaware, in
addition to any other remedy to which they are entitled at law
or in equity.
</DIV>

<P align="center" style="font-size: 10pt;">53

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be duly executed by their respective authorized
officers as of the day and year first above written.
</DIV>

<DIV style="margin-top: 24pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="60%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <B>TRANSKARYOTIC THERAPIES, INC.</B></TD>
</TR>

</TABLE>

<DIV style="margin-top: 48pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="2%"></TD>
    <TD width="58%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD>By:&nbsp;</TD>
    <TD align="left">
    /s/ David D. Pendergast</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 3pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="60%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <DIV style="border-top: 1pt solid #000000; font-size: 1pt; margin-top: 2pt" align="left">&nbsp;</DIV></TD>
</TR>

<TR valign="top"  style="font-size: 10pt;">
    <TD>&nbsp;</TD>
    <TD align="left">
    Name:&nbsp;David D. Pendergast</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="8%"></TD>
    <TD width="52%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD align="left">
    President and Chief Executive Officer</TD>
</TR>

</TABLE>

<DIV style="margin-top: 24pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="60%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <B>SHIRE PHARMACEUTICALS GROUP PLC</B></TD>
</TR>

</TABLE>

<DIV style="margin-top: 48pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="2%"></TD>
    <TD width="58%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD>By:&nbsp;</TD>
    <TD align="left">
    /s/ Matthew Emmens</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 3pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="60%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <DIV style="border-top: 1pt solid #000000; font-size: 1pt; margin-top: 2pt" align="left">&nbsp;</DIV></TD>
</TR>

<TR valign="top"  style="font-size: 10pt;">
    <TD>&nbsp;</TD>
    <TD align="left">
    Name:&nbsp;Matthew Emmens</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="8%"></TD>
    <TD width="52%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD align="left">
    Chief Executive Officer</TD>
</TR>

</TABLE>

<DIV style="margin-top: 24pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="60%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <B>SPARTA ACQUISITION CORPORATION</B></TD>
</TR>

</TABLE>

<DIV style="margin-top: 48pt; margin-left: 0; margin-right: 0; margin-bottom: 0; color: #000000; background: #ffffff;"></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="2%"></TD>
    <TD width="58%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD>By:&nbsp;</TD>
    <TD align="left">
    /s/ Matthew Emmens</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 3pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="60%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <DIV style="border-top: 1pt solid #000000; font-size: 1pt; margin-top: 2pt" align="left">&nbsp;</DIV></TD>
</TR>

<TR valign="top"  style="font-size: 10pt;">
    <TD>&nbsp;</TD>
    <TD align="left">
    Name:&nbsp;Matthew Emmens</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt;">

<TR>
    <TD width="40%"></TD>
    <TD width="8%"></TD>
    <TD width="52%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD align="left">
    Chief Executive Officer</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt;">&nbsp;
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
